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Allium sativum (Knoblauch) besitzt eine sehr lange Tradition in der Medizin. 
Während über die potentiellen gesundheitsfördernden Eigenschaften von Allium 
sativum einiges bekannt ist, weiß man hingegen nichts über eine verwandte 
Pflanze, dem auch im Leipziger Raum weit verbreiteteh Allium ursinum (Bärlauch; 
engl.: wild garlic, ramson), obwohl es seit Jahrhunderten in der Volksmedizin 
eingesetzt wird. Ziel der vorliegenden Studie war es, die möglichen 
Thrombozytenaggregations-hemmenden Eigenschaften beider Allium-Spezies zu 
untersuchen und soweit wie möglich die verantwortlichen Wirkstoffe chemisch zu 
identifizieren. Dazu wurden verschiedene Extrakte (hydrophile und lipophile) 
hergestellt und mittels Dünnschichtchromatographie und HPLC analysiert. Nach 
Identifizierung wirksamer, also aggregationshemmender (s.u.) Extrakte wurde der 
entsprechende Extrakt mittels bioassay-gelenkter Fraktionierung aufgetrennt; die 
nachfolgenden chemischen analysen erfolgten mittels ESI-(Electrospray 
ionization-) Massenspektroskopie und 1d/2d 1H/13C-NMR-Spektroskopie sowie 
funktioneller Testung. Die antiaggregatorische Wirkung wurde an humanen 
Thrombozyten mittels der klassischen turbidimetrischen Methode getestet. Dazu 
wurden die Thrombozyten mit verschiedenen Stimuli (Arachidonsäure, ADP, 
Adrenalin, Kollagen, A23187) mit oder ohne Zusatz der Extrakte, Fraktionen oder 
Sub-Fraktionen aktiviert. 
Extrakte aus beiden Arten, Allium ursinum und Allium sativum, zeigten 
antiaggregatorische Eigenschaften mit EC50 Werten im Bereich von 0.1 mg/ml. Die 
Wirkung kommt über eine Hemmung des ADP-Signalweges zustande vergleichbar 
mit dem Wirkmechanismus der klinisch angewandten Substanz Clopidogrel. Das 
chemische Wirkprinzip in den Extrakten schien eher lipophilen als hydrophilen 
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Charakter zu besitzen. Dieses ist die erste Studie, die eine antiaggregatorische 
Wirkung von Allium ursinum beschreibt. Als eine chemische Struktur, die 
antiaggregatorische Eigenschaften besitzt, konnten aus den Extrakten N-
Sitosterol-3-O-N-D-glucosid mittels ESI und NMR identifiziert werden. Eine 
Abschätzung ergab, dass eine Antiaggregation vermutlich mit 3 bis 5 g der 
getrockneten Blättern erreicht werden kann (Anm.: in der Pharmazie wird häufig 
getrocknetes Pflanzenmaterial verwendet). Eine zweite Substanz mit 
antiaggregatorischer Wirkung konnte als 1-N-D-Galactopyranosid-2,3-bis-
linolenoylglycerat identifiziert werden. Das bei der Herstellung eines 
Phytopharmakons aus diesen Extrakten auftretende Problem des Verlustes von 
aktiven, öligen Komponenten durch die Trocknung der Blätter könnte durch 
Herstellung eines Rohextraktes oder eines Spezialextraktes künftig gelöst werden, 
der in Kapseln mit 120-200 Og z.B. eines Ölextraktes oder Heptanextraktes der 
Allium ursinum-Blätter eine sinnvolle Formulierung darstellen würde, um 
theoretisch die entsprechenden Wirkspiegel zu erreichen. Einschränkend muss 
aber festgehalten werden, dass die hier vorgelegten Untersuchungen in-vitro 
Untersuchungen darstellen und über den in-vivo Metabolismus der Allium-Extrakte 
und der wirksamen Substanzen kaum etwas bekannt ist.  
Die vorgelegte Studie zeigt erstmalig dass Allium ursinum antiaggregatorische 
Wirkungen an Thrombozyten besitzt, und eine ähnliche Wirkung auch mit Allium 
sativum auftritt, die beide künftig in-vivo untersucht werden sollten. Es konnten N-
Sitosterol-3-O-N-D-glucosid und 1-N-D-Galactopyranosid-2, 3-bis-linolenoyl- 
glycerat als zwei der aktiven antiaggregatorische Prinzipien identifiziert werden. 
 
xSummary (English) 
Allium sativum has a long tradition in medicine. While much is known about its 
potential healthy effects, nearly nothing is known about Allium ursinum (wild garlic, 
ramson), which is very common in the area of Leipzig and has been used as a 
herbal remedy since centuries. The aim of the present study was to assess a 
potential anti-platelet activity of these two Allium species and to try to identify the 
chemical active principle. For that purpose various extracts (hydrophilic and 
lipophilic) were prepared from Allium sativum and Allium ursinum, and analysed 
using thin layer chromatography and HPLC. After identifying an active, i.e. 
antiaggregatory extract (see below), the corresponding extract was subjected to 
bioassay-guided fractionation and isolation for subsequent chemical analysis by 
ESI (electrospray ionization) mass spectroscopy, 1d/2d 1H/13C NMR spectroscopy 
and functional testing. Anti-platelet activity was assessed in human platelets 
(platelet rich plasma) using a classical turbidimetric method. Platelets were 
stimulated with various agonists (arachidonic acid, ADP, epinephrine, collagen, 
A23187) with and without the addition of the extracts or the fractions /sub-
fractions.  
Both Allium ursinum and Allium sativum extracts exert antiaggregatory effects with 
EC50 values around 0.1 mg/ml. The garlic extracts are acting by inhibition of the 
ADP pathway comparable as known from the clinically used drug clopidegrel. The 
pharmacological active antiaggregatory component of the extracts appears to be 
lipophilic rather than hydrophilic. This is the first report on an antiplatelet activity of 
Allium ursinum. One final structure determined by ESI-MS and NMR spectroscopy 
which exerts the antiplatelets inhibitory effect is N-sitosterol-3-O-N-D-glucoside. A 
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second compound with antiaggregatory activity was identified as 1-N-D-
galactopyranoside-2, 3-bis-linolenic glycerate. It is considered that about three up 
to five grams of dried leaves might be enough to exert antiaggregatory effects (in 
pharmacy normally dried plant material is used in therapy).  
The problem of loosing the active volatile oily components by drying the leaves in 
future studies looking for the clinical use may be solved by looking for a raw or a 
refined extract which would be the form of a real phytomedical drug; for example 
capsules containing about 120 to 200 micrograms of an alcoholic or better an 
heptane / oily extract gained from wild garlic leaves would be an useful drug 
formulation to reach respective concentrations in blood. However, we have to 
admit that since our investigations were in-vitro, the in-vivo situation is somewhat 
different due to the metabolism, which is nearly unknown. Nevertheless, this study 
shows for the first time that Allium ursinum does exert anti-platelet activity and that 
both Allium species can unfold antiaggregatory effects which are worth to be 
investigated in subsequent in-vivo studies. N-sitosterol-3-O-N-D-glucoside and 1-N-
D-galactopyranoside-2, 3-bis-linolenic glycerate could be identified as two of the 





1.1 Historical background  
Garlic is well known across the centuries. It was used as a medicine by early 
civilizations (Rivlin 2006 [1], Thomson and Ali 2003 [2]). It has been described as 
early as 1500 BC by the Egyptians as part of their ordinary diet as well as for its 
supposed role in the treatment of variety of diseases. Garlic was mentioned as a 
medicine in some religions (Green and Polydoris 1993 [3], Kahn 1996 [4], Moyers 
1996 [5] Bergner 1996 [6]). In ancient Greece it was called the “performance 
enhancing" agent where it was given as a food for the athletes to supply them with 
power before competitions (Green and Polydoris 1993 [3], Lawson 1998 [7], Rivlin 
2001 [8]). The earliest report of its cardioprotictive effect dates back to the Ancient 
Romans who thought garlic cleans the arteries (Bergner 1996 [6], Riddle 1996 [9]). 
Chinese used garlic as a food preservative as well as a medicine for 
gastrointestinal problems and respiratory disease (Woodward 1996 [10]). Old 
Indians believed that it has a good effect for the treatment of joint infections, heart 
and digestive diseases which is well known nowadays (Woodward 1996 [10], 
Rivlin 1998 [11]). As attention has been made more for the usage of plants in the 
early Renaissance, garlic has taken some importance as it was chosen to be 
grown for medical purposes (Moyers 1996 [5]). 
While garlic was somehow a kind of medicine for the wealthy class in England, still 
it has been used as a daily food for the working class. It was well known for its 
effect on tooth ache, constipation and treatment of dropsy and plaque. The early 
Americans knew garlic by the sailors who imported it from Europe especially 
France and Portugal. It was accepted by a lot of people. Treatment of respiratory, 
1 Introduction 
2
cardiovascular disease and infections was its main purpose of use (Moyers 1996 
[5]). 
 
1.2 Antiplatelets drugs: Types and side effects 
Antiplatelets drugs have been widely used for prevention and treatment of 
coronary artery disease, peripheral vascular disease, stroke and transient 
ischemic attacks. As anticoagulant drugs are used for the treatment of venous 
thrombosis, antiplatelets drugs are mostly effective in the treatment or prevention 
of arterial clots which contain mainly of platelets. There are four major classes of 
Antiplatelets drugs: cyclooxygenase inhibitors (acetylsalicylic acid / AspirinTM), 
thienopyridines (Clopidogrel, Ticlopidine), phosphodiesterase inhibitors 
(Dipyridamole), glycoprotein IIb/IIIa receptor antagonists. In general all 
Antiplatelets drugs can cause bleeding; precautions should be taken seriously with 
patients suffering from gastrointestinal hemorrhage (peptic ulcer disease) and 
uncontrolled hypertension. Most side effects are associated with the below drugs: 
 
1 – Acetylsalicylic acid 
Acetylsalicylic acid or AspirinTM is the most used antiplatelets drug worldwide. It is 
rapidly absorbed from the gastrointestinal tract with a peak concentration reached 
in 30-40 minutes. Side effects of aspirin intake are dose dependent. It ranges from 
simple nausea, epigastric pain, heart burn to massive upper gastrointestinal (GI) 
hemorrhage. The risk of GI bleeding and stroke increase significantly with high 
dose Aspirin intake (500-1500 mg/day) (Roderick et al. 1993 [12], Geraghty et al. 
2010 [13], Taylor et al. 1999 [14]). Furthermore long duration treatment increases 
the risk of these side effects (Derry and Loke 2000 [15]). The addition of a second 
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antiplatelets drug to Aspirin in order to increase it’s efficacy might be of benefit but 
needs further investigation (Antithrombotic Trialists' Collaboration 2002 [16]). 
 
2 – Clopidogrel and ticlopidine 
The thienopyridine derivatives (clopidogrel and ticlopidine) exert their action of 
platelets deactivation through ADP receptor inhibition on the platelets. They are 
mainly metabolized in the liver. If we compare them with Aspirin, thienopyridines 
are associated with a lower risk of GI hemorrhage and upper-GI symptoms but a 
higher incidence of skin rash and diarrhea (Hankey et al. 2000 [17]). 
Ticlopidine and Clopidogrel are well known for their serious complication of 
causing thrombotic thrombocytopenic purpura which if not treated will cause a fatal 
result. Clopidogrel has fewer side effects in comparison to Ticlopidine. It could be 
used as substitute for Aspirin in patients with intolerance or contraindication 
(Zakarija A et al. 2009 [18], Zakarija A et al .2004 [19], Sudlow et al .2009 [20]). 
3 – Glycoprotein IIb/IIIa receptor blockers 
Thrombocytopenia is the most common side effect associated with this group of 
antiplatelets drugs. It ranges from the mild form to the severe one where platelets 




1.3 Need for new approach 
Although Antiplatelets drugs are used by so many patients for treatment purposes 
or as prophylactic agents and still prescribed by many physicians on daily basis 
still we have to answer some very important questions: 
1. Are they used in the correct manner? 
2. Are they prescribed for the correct diagnosis?  
3. Dose their benefits overweighs their potential side effects? 
It is really clear that these drugs are more dangerous and could be life threatening 
in some patients who already have the potential to develop complications because 
of the preexisting disease or severe sensitivity (peptic ulcer disease, bleeding 
tendency and other adverse effects in context with cyclooxygenase inhibition). The 
common complications of the antiplatelets drugs usage and their side effects 
stmiulate a challenge to find a new generation of structures who have more 
favorable points. 
The perfect supposed new generation structures should have:  
1. Less cost than the already existing drugs because some of these agents 
are comparatively expensive, especially in the third world countries. 
2. Fewer side effects (i.e. less gastrointestinal disturbances) as well as no or 
less bleeding from preexisting peptic ulcer disease… etc. 
3. The ability to be used effectively as it is recommended without the need to 
stop it few days before or at time of surgery. 
As garlic has been previously known for it’s antiplatelets action, it was chosen here 
to be studied for the possibility of being the new generation with the perfect action. 
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1.4 Allium sativum (common garlic) 
Allium sativum is the scientific name of the common garlic. It is derived from two 
names, first from the Celtic word “all“ which means burning and the second 
sativum which is latin and mean cultivated or planted. Garlic is an English word 
and it is derived from its Anglo-Saxon origin, gar-leac. This name was chosen 
because of its flowering stalk1.
The root bulb is the part of the garlic that contains the active components 
presented as steam-distilled oil, dehydrated or fresh. Allicin is the major medicinal 
compound obtained from garlic. It appears to be the active substance of garlic. It is 
part of the thiosulfinates which belong to the sulfur-containing compounds where 
garlic is known to be so rich with. Allicin is not a native compound of garlic, it is 
produced when garlic is finely chopped or crushed. The amino acid-like alliin (S-
allylcysteine sulphoxide) reacts with the enzyme allinase (where is also located in 
the plant cell) which transforms allicin into aliin (diallyl thiosulphinate). Raw garlic 
appears to be inactive unless it is chopped, crushed, or chewed. As the acidity of 
the stomach inhibits the action of the enzyme alliinase the effectivety of garlic 
preparations should be protected by the usage of enteric coats. Since the enzyme 
alliinase is inactivated by heat, cooked garlic looses effectivity, so it is advisable to 
add garlic at the end of the recipe rather than from the start.  
There are three famous major types of garlic preparations which are used either 
for scientific studies or as a medicine: 
1 - Raw garlic homogenate which is used mainly for intensive scientific study. It 
is the same as the aqueous extract of garlic. Allicin (allyl 2-
propenthiosulfinate or diallyl thiosulfinate) is the active principle. The 
 
1 Anonymous: Garlic. Lawrence Review of Natural Products 1994; April, pp. 1-4 
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composition of garlic powder is the same as fresh garlic and this apply also 
for the allinase activity. Garlic powder is simply dehydrated, pulverized garlic 
glove (Lawson 1998 [5]).  
For gaining garlic powder often is treated with hot ethanolic steam to 
inactivate the enzymes. This powder has to be incubated in water for some 
minutes to reactivate alliinase. 
2 - Aged garlic extract (AGE). The name AGE refers to 20 months storage of raw 
garlic slices in 15- 20% ethanol. This procedure causes considerable loss of 
allicin and enhances the activity of newer compounds such as S-allylcysteine 
(SAS), S–allylmercapto-cysteine, allixin and selenium which are stable, highly 
bioavailable and antioxidative (Borek 2001 [22]). 
3 - Steam distilled garlic oil which is used mainly in medicine. It is prepared by 
process of steam distillation. It consists of diallyl sulfides (57%), allyl methyl 
sulfides (37%), dimethyl sulfides (6%) and mono- to hexa sulfides (Lawson 
1998 [5]). 
Garlic seems to be a very famous plant for culinary and medical use since long 
time ago. There has been renewd interest for deeper investigations of the 
mechanism of garlic action using new technologies (Bhagyalakshmi et al. 2005 
[23]). The well known antioxidant property of garlic species opened the horizon for 
the possibility of its use in the coming future as a solution for the chronic disabling 
process associated with aging (Rahman 2003 [24], Rahman 2007 [25]). As there is 
insufficient data at present to prove the efficacy of garlic in the prevention or 
treatment of chronic diseases (diabetes mellitus, hypertention) and viral infections 
(common cold), more clinical studies and advanced research need to be 
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conducted in order to investigate its possible beneficial role (Liu CT et al. 2007 
[26], Pittler and Ernst 2007 [27], Lissiman et al. 2009 [28]). 
Garlic exerts its preventive properties and medicinal action through production of 
more than 200 chemicals: sulphuric compounds, enzymes, volatile oils, 
carbohydrates, minerals, amino acids, flavonoids and vitamins like ascorbic acid 
(C), F-tocopherol (E), carotinoids (provitamin A), thiamine (B1), riboflavin (B2) and 
niacin (Ayaz and Alpsoy 2007 [29]). Some studies have showed that garlic may 
exert some protection against some kinds of cancer (Thomson and Ali 2003 [2]). 
One of the mechanisms assumed that garlic fights cancer is enhancing the natural 
immune system of the body rather than deactivating it by the invasive cells 
(stimulates the release of IL-2, TNFF and IFNE and enhance natural killer cells, 
lymphocytes proliferation, macrophage phagocytosis). Garlic antioxidant property 
and stimulation of cytochrome P450 enzymes is another hypothesis of carcinogens 
detoxification by garlic (Butt et al. 2009 [30], Lamm and Riggs 2001 [31]). 
While there has been little evidence-based data which support its role in reduction 
of certain types of cancer such as colon, esophageal, larynx, oral, ovary, prostate 
or renal cell cancers, no definitive role could be identified in other types such as 
breast, lung, gastric or endometrial carcinoma (Kim and Kwon 2008 [32]). The role 
of garlic as antimicrobial agent is known through its antibacterial, antiviral, 
antifungal and antiprotozoal action (Harris et al. 2001 [33], Goncagul and Ayaz 
2010 [34]). The well known active compound in garlic, allicin, exerts its activity 
against wide range of gram positive and gram negative bacteria, Candida 
albicans, Entamoeba histolytica, Giardia lamblia. The chemical reaction of allicin 
with thiol groups of various enzymes is responsible for its antimicrobial activity 
(Ankri and Mirelman 1999 [35]). 
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Morever, a lot of studies were focused on the use of garlic in cardiovascular 
diseases treatment and concomitant events such as fibrinolytic activity 
enhancement, normalization of plasma lipids, platelets aggregation inhibition and 
control of some metabolic disorders (Agarwal 1996 [36], Bordia 1978 [37]; Neil et 
al. 1996 [38], Steiner et al. 1996 [39], Efendy et al 1997 [40], Sobenin et al 2008 
[41], Andrianova et al 2004 [42]). While  there is some data to support the 
antiathersclerotic effect of garlic consumption in humans, the antithromobotic 
activity looks promising but needs more data to have clear conclusions (Brace 
2002 [43], Wojcikowski et al. 2007 [44], Rahman 2007 [45], Ackermann 2001 [46]). 
The progression of the cardiovascular disease has been inversely correlated to the 
consumption of garlic. It has been shown to inhibit enzymes involved in the lipid 
synthesis, increase the antioxidant status and most striking is its ability of platelets 
aggregation inhibition (Rahman and Lowe 2006 [47], Lau 2006 [48]). One of the 
major factors that contribute to the cardiovascular disease as well as dementia 
which both increase with age is the oxidative damage. Aged garlic extract or 
“kyolic” reduces the risk of these diseases by its antioxidant effect (Borek 2006 
[49]). One of the major disadvantages of garlic consumption is the garlic breath 
and body order which are well known complaints by many people.  
Allergic reactions (systemic or local), burns, alteration of platelets function, drug 
interaction are also have been encountered (Borrelli et al 2007 [50]).  
In fresh garlic bulbs 0.35-1.15% alliin (S-allyl-L-(+)-cysteinsulfoxid) has been found 
as well as the enzyme alliinase, which degrades alliin to allicin (allyl-2-
propenthiosulfinate). Allicin decomposes to several volatile strong smelling sulphur 
compounds, such as E- and Z-ajoene and vinyldithiines (Block1992 [51], Sticher 
1991 [52], Jansen et al. 1989 [53], Krest and Keusgen 1999 [54]). 
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High doses of garlic consumption may prolong the bleeding time, so it is advisable 
to stop garlic seven to ten days before any surgical procedure. Clopidogrel 
(Sanofi-aventis and Bristol-Myers-Quibb SNC 2006 [55]) which is a very famous 
antiplatelet drug used especially for stenting procedures should be stopped seven 
days before the day of surgery to reduce the risk of bleeding. The usage of aged 
garlic extract along with oral anticoagulation therapy (coumarin derivatives) seems 
to be safe and has no serious potential hemorrhagic risk in closely monitored 
patients on warfarin anticoagulation therapy. Despite the fact that it is not 
obviously interfered with other drug metabolism, still one should take care if other 
anticoagulant drugs are used (Tattelman 2005 [56], Macan 2006 [57]). 
 
1.5 Allium ursinum (wild garlic) 
Wild garlic (bear’s garlic, wood garlic) grows in fens and river woods of Central 
Europe. The fresh leaves or dried herb is used in local cuisines of Europe. Since it 
has not been cultivated yet, it didn’t gain any importance until several years ago 
where people started to look for this as it is natural. Since its leaves could be 
easily mistaken with other poisonous plants such as lily of the valley and autumn 





Fig (1): a photo of wild Garlic in the Botanical garden Leipzig University.  
 
In the medieval medicine the leaves of Allium ursinum were used as a therapy for 
cardiovascular diseases and upper GI disturbances (Richter 1999 [59]). At that 
time it was named “herba salutaris” for its health-enhancing effects. Well known 
physicians such as Ibn Bultan (1000-1066) highly prescribed it. More recently, in 
our days a cardioprotective action of Allium ursinum was described in-vitro (Rietz 
et al. 1993 [60]). While all portions of Allium ursinum were found to exhibit 
antioxidant property, the leaves were found to have the highest activity (Stajner et 
al. 2008 [61]). The whole vegetation period is from March to June. It is just before 
flowering time where contents are up to 0.4% of total cysteine sulfoxides, that 
means between March and April is best time to harvest Allium ursinum. In this 
period the amount of volatiles precursors are also the highest. Alliin and isoalliin 
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were the main cysteine sulfoxides found. Although the alliinase of Allium ursinum 
exhibit the same properties of the Allium sativum, the substrate specificity has 
some differences (Schmitt et al. 2005 [62]). If the plants are dried, many of the 
compounds are degraded so that the use of the fresh plant is recommended or 
alternatively it has to be lyophilised. In the fresh leaves of Allium ursinum 0.005% 
allicin and 0.07% methyl-L-cysteinsulfoxid as well as E-glutamylpeptides such as 
E-glutamylallylcysteinsulfoxid have been found (Wagner and Sendl 1990 [63], 
Matsuura et al. 1996 [64]), E-glutamylallylcysteinsulfoxid reported to inhibit 
angiotensin-converting enzyme (Sendl et al. 1992 [65], Rietz et al. 1993 [60]). 
Other components such as lectins and flavonoids have been found (Carotenuto et 
al. 1996 [66], Smeets et al. 1997 [67]). Flavonoids were described to be 
responsible for inhibition of platelets aggregation in humans (Carotenuto A et al. 
1996 [66]). As a property similar to other Allium species, it has a marked 
antioxidant activity because of the high content of carotenoids, chlorophylls, 
flavonoids and low toxic oxygen radicals (Stajner et al. 2006 [68]). Some studies 
have shown that Allium ursinum can be a substitute for garlic (Sendl et al. 1992 
[65]). On an experimental level Allium ursinum is found to be more beneficial than 
Allium sativum at a certain concentration. Thus, Allium ursinum showed a higher 
effect in increasing HDL and decreasing of total cholesterol as well as lowering the 
systemic blood pressure (Peuss et al. 2001 [69]).  
It is supposed that Allium ursinum manufactured products might have more 
advantages over that of Allium sativum for several reasons: 
1- They are odorless: Allium ursinum contains considerable amounts of 
chlorophyll, which during digestion binds nitrogen and prevents the 
development of smell associated with garlic breakdown products. 
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2- It has more active substances: more amounts of ajoene (a degraded form of 
allicin), y-glutamyl peptides (GLUT), and more adenosine than in Allium 
sativum.
3- Some of the active substances present in A. ursinum products are not found 
in A. sativum and if found it needs to be taken in larger quantities.  
However, at present there is nearly nothing known on a possible medical use of 
Allium ursinum based on experimental pharmacological investigations. 
 
1.6 Aims of the study 
The aim of the present study was therefore to investigate whether Allium ursinum 
extracts may exert anti-platelet effects and if so, what is the probable mechanism 
of action and which active compounds are responsible for this activity. 
Furthermore, the investigations were performed to investigate whether the effects 
observed are dose-dependent. In parallel, bioassay-guided isolation of the active 
principles should be performed for chemical characterization of the bioactive 
compounds in Allium ursinum.
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2. Materials and Methods                  
2.1 Material 
All equipment, devices and glassware used for preparing extracts and samples are 
specified below. All chemicals, solvents and expendable items are itemized in the 
following tables. 
 
2.1.1. Equipment and Devices 
Table 1  
Analytic Scales MC1 Analytic AC 210 P SARTORIUS 
Centrifuge Labofuge 400 R HERAEUS  
Lyophilization apparatus Lyovac GT 2-E SRK 
With rotary vane vacuum pump Trivac B LEYBOLD 
Magnetic Stirrer HEIDOLPH MR 3001  
Drying Cabinet Type T 6120 HERAEUS 
Pipets EPPENDORF 
200 – 1000 µl
50 -    200 µl
Rotary evaporator Laborota 4001 HEIDOLPH with membrane pump 
VACUUBRAND CVC2 Type M2 2C 
Scales PT 310 SARTORIUS 
Shaker MLW THYS2 VEB Labortechnik Ilmenau 
Ultrasonic Bath Sonorex Super RK 103H BANDELIN electronics Berlin 
Ultraturrax T25 JANKE & KUNKEL IKA Labortechnik 
Ultraturrax T50 JANKE & KUNKEL IKA Labortechnik 
UV Lamp UVIS Type 131100 DESAGA 
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2.1.2 Glassware used in the work   
Table 2: Glassware  
 Item Pieces 
Atomizer (type test-tube atomizer) 2 
Beaker 5000 ml 1 
Column with frit, length = 32 cm, 5.0 cm in diameter 
Column, length = 36.5 cm, 4.0 cm in diameter 




Erlenmeyer flasks   250 ml  
Erlenmeyer flasks   500 ml 




Feeding bottles, 2000 ml 2 
Frit G3 10 cm in diameter 4 
Funnels, 15 cm in diameter 
Funnels,   7 cm in diameter 
2
4
Glass capillaries for TLC 2 
Glass stick length 40 cm 1 
Separation funnel 1000 ml 3 
Round flasks  100 ml  
Round flasks  250 ml 
Round flasks  500 ml 





Rubber collars 5 cm in diameter 2 
Steam distillation apparatus according Ph.Eur. 1 
TLC chambers with ground flange and lid with ground lid flange 
for TLC sheets 20 x 20 cm DESAGA 
3
TLC chambers with ground flange and lid with ground lid flange 
for TLC sheets 10 x 10 cm DESAGA 
4
2 Materials and Methods   
15
2.1.3 Chemicals, reference substances and other materials  
Table 3: Chemicals, reference substances 
Anis aldehyde (4-Methoxybenaldehyde), MERCK-SCHUCHARDT 
Alanine p.a. VEB Berlin Chemie 
Catechin ROTH 
Desglucoruscoside 
Ninhydrine VEB Berlin Chemie 
Sulphuric acid 96-98%, GRÜSSING 
Vanillin p.a. MERCK 
Falcon tubes 50 ml VWR 
Filters, 200mm, 150 mm and 75 mm in diameter 
Hyperoside MERCK 
Pipet tips for Eppendorf pipet 200 – 1000 µl
Pipet tips for Eppendorf pipet   50 – 200 µl
Rutin (Rutoside) ROTH 
Silica gel for column chromatography, 
particle size 0.040 – 0.063 mm, MERCK 
particle size 0.063 – 0.200 mm, MERCK 
TLC sheets silica gel 60 with fluorescence indicator F254 20x20 cm MERCK 
Tubes EPPENDORF  
Solvents 
Acetic acid, commercially pure, BASF 
Butanol, commercially pure, BASF 
Choroforme, commercially pure, BASF, distilled 
Ethanol, commercially pure, denaturated with 1,3% Methyl ethyl ketone (MEK), 
BASF, distilled 
Ethyl acetate, commercially pure BASF, distilled 
Methanol, commercially pure, BASF, distilled 
Water, demineralized  
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2.1.4 Plant material: fresh Allium sativum bulbs were purchased form market and 
fresh Allium ursinum leaves were collected in the Botanical Garden of Leipzig 
University and in the natural habitat in the forests surrounding Leipzig. 
 
2.2 Methods  
2.2.1 Methods of extraction  
2.2.1.1 Extract preparation 
This step was done for comparison of wild garlic to common garlic. The gloves of 
garlic were removed from the bulb and peeled. For general testing of 
antiaggregatory activity, aqueous and methanolic extracts were gained from Allium 
sativum bulbs and fresh Allium ursinum leaves which were yielded by maceration. 
Five grams of plant material were blended in 50 ml methanol using an ultraturrax 
T25 (Janke & Kunkel). Another 5 g of both materials were treated accordingly in 
aqueous medium.The mixtures were stirred for 3 hours at room tempreture.After 
filtering maceration was done three times using a Heidolph MR 3001 K. The 
filtrates were combined and dried in vacuo at 40°C bath temperature and 
afterwards subjected to lyophilization. The dried extracts were frozen and kept at -
20°C. The yields of the dry extracts are shown in Table 4. 
 

















Two TLC were carried out (TLC alliins and allicins, fig.10 and TLC saponosides, 
fig. 11) and all yields subjected to blood testing, fig. 13.  
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2.2.1.2 Steam distillation 
Steam distillation is used to achieve volatile compounds from plants. In 
pharmaceutical biology the steam distillation apparatus according Ph.Eur. is used 
for isolation and quantification of the essential oil from plant drugs. In our 
experiment this test arrangement was used in order to achieve the volatile 
compounds from fresh Allium ursinum leaves. Therefore a 2000ml-round flask was 
filled with 1000 ml water, the steam distillation apparatus was attached. The steam 
distillation apparatus was filled with water by fill nozzle till a stable water level was 
obtained. The round flask was heated by a hemispherical heating mantle till boiling 
where at the hole of the lug remained closed. This idling is required for regulating 
heat in order to reach a distillation velocity of three ml per minute. Afterwards 
distillation was stopped; the lug was opened to obtain the normal water level. 
Through the lug the 3 ml-extention 3 ml of pentane was added. The Ph.Eur. 
proposes xylol for retaining essential oils, in some cases no xylol (e.g. Thymi 
herba Ph.Eur.) is added. In the present work xylol was replaced by pentane since 
xylol has a high boiling point. Xylol can hardly be removed and it could not be 
excluded that xylol may highly influence platelets aggregation testing itself. 
Pentane can be removed easily without reversal of essential oil components since 
its boiling point is below 30°C. Subsequently 500g fresh leaves were transferred 
into the round flask and steam distillation was restarted. The hot water steam 
condenses in the ball condenser, where the other lipophilic volatile substances 
separate from the cooled water. Therefore the volatiles are retained and 
accumulate in the pentane phase placed in the extension. Steam distillation was 
done for four hours; after cooling of the entire arrangement the essential oil was 
obtained by carefully opening of the three-way cock. After water was removed 
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from the measuring tube, the volume of the pentane phase could be metered. By 
subtraction of the volume of pentane employed, a volume of 0.8 ml essential oil 
could be determined. Pentane was removed by slightly warming in water at bath 
temperature of 40°C, a strong smelling greenish yellow oil could be achieved. 
Thus the essential oil could be used for platelets aggregation test.
Fig (2): Steam distillation apparatus according Ph.Eur. In our experiment 
xylol was replaced by pentane (source: Pharmacopoea europaea, 
General methods, chapter 2.8.12: determination of essential oils in 
plant drugs). 
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2.2.2   Methods of characterization 
2.2.2.1 Thin layer chromatography  
Thin layer chromatography (TLC) is a sensitive and effective analytical method, 
which can be performed easily and quickly. TLC enables to achieve precise 
separations of mixtures of high complexity, while only very small sample amounts 
in ranges of some milligrams are needed. Even nanograms of single substances 
can be detected. This method is highly suitable for separations of plant extracts 
based on their complex constituents. Usually normal phase TLC is used in 
phytochemical analytics. The principle of normal phase TLC is the application of a 
polar stationary phase which is surfaced on an aluminium sheet or on glass. This 
stationary phase mostly consists of silica gel; aluminium oxide and cellulose are 
other common stationary phases used in TLC methods. The mobile phase is the 
liquid eluent and can consist of one solvent or a mixture of solvents of different 
polarities, but the mobile phase is less polar than the stationary phase. Common 
mobile phase components are hexane, dichloromethane and ethyl acetate, small 
volumes of polar solvents like alcohols, organic acids and water can be added. 
TLC is performed in a TLC chamber in which the bottom is covered by the eluent. 
Samples are dissolved and put on the TLC surface using small capillaries. For 
separation the TLC sheet is dipped into the solvent and the chamber is closed. 
The solvent is sucked by the dry polar surface by capillary force; when the solvent 
has reached the top of the TLC sheet, separation is done as shown in figure 4. 
Duration of development is dependent on polarity of the eluent. The higher the 
polarity of the eluent the longer is time of development. Separation principle is 
based on polarity of the stationary phase, mobile phase and sample. Components 
are separated according to their different rates of ascending the stationary phase, 
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expressed by their individual retention factors, also called Rf values. Compounds 
of less polarity display fewer interactions with the stationary phase and therefore 
cover more distance than more polar compounds. Single components of mixture 
can be characterized by their Rf values (figure 3). This value is displayed by the 
quotient of the distance covered by the respective substance and of the solvent 
(solvent front). The retention factor is an individual property of each chemical 
compound depending on stationary phase and mobile phase used. Therefore, it 
allows drawing conclusions on the chemical nature of a compound respective 
polarity. The interactions between each component of a sample and the stationary 
phase as well as the mobile phase display the principle of all kinds of 
chromatographic methods as shown in figure 5. After TLC development separated 
substances can be detected by light. Compounds with a great system of double 
bonds like carotenes can be detected by visible light (VIS) by means of their own 
colour; substances possessing a smaller chromophore i.e. flavonoids can be 
detected by long wavelength UV light showing fluorescent spots. Compounds 
having a very small double bond system i.e. small phenolic compound occur as 
erasing spots in short wavelength UV light. Regarding many natural compounds 
like sugars and saponosides a system of b-electrons is too small or lacking; in this 
case, compounds can be visualized by spray reagents. Today, a large assortment 
exists enabling to detect nearly all natural products structures individually. UV-
activities and colouring by spray reagent can give useful informations about 
structural properties of a chemical compound. Therefore, why TLC till now is a 
popular method widely used in research and in industry; especially in 
pharmaceutical sciences. This standard method allows the analysis for identity 
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and quality of plant material and plant extracts. For basic information and 
fundamental methodology a TLC manual [70] was consulted. 
 
In the present experiment thin layer chromatography was used to identify the 
chemical compounds of the Allium sativum and Allium ursinum extracts. TLC was 
carried out on TLC sheets silica gel 60 with fluorescence indicator F254 20x20 cm 
(MERCK), for testing of the fractions small TLC sheets (10 x 10 cm) were used. 
Detection of the different compounds was done under UV light with wavelengths of 
254 nm and 366 nm and by spraying with reagents according to the type of 
compounds. Several different types of TLCs were carried out to identify (1) 
polyphenols (flavonoids and tannins) as well as (2) alliins / allicins and (3) 
saponosides, respectively. All TLCs were carried out on silica gel F-254 60 Merck. 
After development the plates were analyzed below UV 254 nm and 366 nm. In 
general, TLC separation, spot colouring and Rf values of compounds were 
compared to the tables shown in a TLC atlas [71]. 
 
2.2.2.1.1 TLC of polyphenols (flavonoids and tannins) 
The eluent used was ethyl acetate: methanol: water 77:13:10 (Grötzinger K 2005 
[72]). TLC was carried out on TLC sheets silica gel 60 with fluorescence indicator 
F254 20x20 cm. Rutin, hyperoside and catechins were taken for reference. 
Therefore 5 mg of rutin, 5 mg of hyperoside and 5 mg of catechin were dissolved 
in 5 ml methanol. Detection was made using UV light of wavelength 254 nm and 
366 nm. Flavons and flavonols were visualized as ultraviolet erasing (254 nm) 
spots, fluorescent (366 nm) in orange; proanthocyanidins were detected as 
ultraviolet erasing spots. TLC was sprayed with vanillin-sulfuric acid reagent, 
which detects phenolic compounds. After heating at 110° C for 10 min flavonols 
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and flavons were shown as deep yellow spots, proanthocyanidins were visualized 
as intensive red spots. Spray reagents: 1 g of vanillin was dissolved in 100 ml 
methanol. 10 ml sulfuric acid was mixed with 100 ml methanol. First vanillin 
solution was sprayed on TLC, followed by the methanolic sulfuric acid. 
 
2.2.2.1.2. TLC of alliins / allicins 
TLC was performed according to (Kanaki and Rajani 2005 [73]). For analysis of 
the alliins and allicins n-butanol: acetic acid: water 60:40:20 was chosen as 
solvent system. The amino acid Alanin was used as reference showing similar Rf 
according to alliin. Therefore 5 mg of alanin were dissolved in 1.5 ml methanol. 
Detection was made by spraying with ninhydrine reagent. Spray reagent for 
detection of amino (-NH2) groups: 200 mg of ninhydrine was dissolved in 100 ml 
water. After heating at 100° C for 5 min alanin and the alliins could be detected as 
red or pink spots, while allicins were visualized as orange spots in VIS.  
 
2.2.2.1.3 TLC of saponosides 
In the present experiment a solvent was chosen, which was proven of value in 
separation of steroidal saponosides common in the species Allium. TLCs were first 
done according to (Zou et al. 2001 [74], Rauwald and Janßen 1988 [75, 76]). 
Since this separation was not sufficient, the solvent was modified to improve the 
separation. It could be shown, that chloroform: methanol: water 60:40:10 was the 
best system for separation of saponosides contained in Allium ursinum and in 
Allium sativum. Since steroidal saponins from Allium species were not available, 
desglucoruscoside was used as reference. Desglucoruscoside is a steroidal 
saponoside which had been isolated from Ruscus aculeatus by Rauwald and 
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Janßen 1988 [75]. Saponosides were detected by spraying the TLC with 
anisaldehyde-sulphuric acid and developing at 120°C. Saponosides were shown 
as greenish brown spots in visible light. 
 
Fig (3): Model for TLC separation 
Fig (4): TLC method using a TLC chamber with solvent saturated 
atmosphere. (Figure 4 was modified from reference number [70]) 
The Rf value of each compound is 
calculated from the measured distance 
covered by the solvent (S) and by the 
respective compound (C): 
 
Rf = S [cm] / C [cm] 
Eluent (solvent)
mobile and stationary 
front of the solvent
dry coat 
sorbtive saturation 
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Fig (5): principle of separation based on the different interactions between 
stationary phase, mobile phase and molecules in the sample 
 

























































Fig (6): substances used as markers and references for TLC analysis to 
determine the group of active compounds. Desglucoruscoside was used as 
an analogue for the saponosides, catechin was chosen as a reference for 
oligomeric proanthocyanidins, and, rutin and hyperoside were the 
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2.2.2.2      HPLC (High performance liquid chromatography) 
2.2.2.2.1   Definition of the HPLC  
 HPLC is a special sort of column chromatography in which the mobile phase is 
forwarded by pumps instead of gravity. Therefore high pressures can be produced 
implying fast pass of the solvent through the stationary phase. Consequently 
HPLC means scarcely diffusion of the single compounds and higher selectivity of 
separation. HPLC is widely used for identifications and quantifications; but it also 
can be used for isolations of single compounds as preparative HPLC. 
HPLC equipment, also shown in fig. 7, consists of the column, reservoirs for the 
solvents, a high pressure pump system, injection system and a detector. In most 
case the column is connected with a precolumn in order to protect the column from 
insoluble particles. The column exists of a steel tube where in the solid phase is 
densely packed; solvent is moved through capillaries made of steel or stable PVC. 
Solvent is forwarded by the pumps; therefore the flexible tube is jointed with a filter 
system for protection of the pump systems from dust particles. The pumps used in 
analytical HPLC can handle volumes up to 10 ml per minute. The injection system 
consists of a sample loop and an injection valve, by which the sample loop can be 
closed when loading the sample and opened for giving the sample onto the 
column. Concerning the detector, there is a variety of detectors for many different 
requirements; in pharmacy and chemistry the UV detector is the most popular one. 
The simple UV detectors with a turnable channel for one wavelength between 190 
and 800 nm are very sensitive. Today the photodiode array (PDA) detectors are 
preferred; they are less sensitive, but they enable to irradiate all wavelengthes 
ranging from 190 nm and 600 nm simultaneously, so the complete UV-VIS 
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absorption spectrum of any compound can be measured. HPLC also can be 
coupled with MS or NMR techniques. 
In modern HPLC methods reversed phases are used as stationary phase; the 
corresponding mobile phase is an aqueous system occasional containing alcohols, 
polar organic solvents, lyes or acids. This HPLC system is required for most 
medicinal plant drugs by the Pharmacopoea Europaea (Ph. Eur.). 
 
Fig (7): Simple illustration demonstrating HPLC equipment 
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2.2.2.2.2 HPLC in our experiment  




Nucleosil® 100-5 C18 e.c. 250 x 4 Macherey-Nagel 
(e.c. = endcapped, particle size = 5 µm, length = 
250 mm, inner diameter =4 mm) 
Precolumn KS 11/4 Nucleosil® 100-5 C18 Macherey-Nagel 
Disposable syringe filter Chromafil® GF/PET-45/25 (pore size 0.45 5 µm) 
Macherey-Nagel 
MiccroliterTM Syringe  25µl, Hamilton 
Methanol Licrosolv® gradient grade Merck 
Acetonitril Licrosolv® gradient grade Merck 
Water Licrosolv® gradient grade Merck 
Formic acid 99-100% BASF 
Pumps: Rainin Dynamax Solvent Delivery System 
Model SD 300 with pressure module 7101-080 
Injection system Rheodyne 7125 
Detector: Absorbance detector Model UV-1 with 
xenon lamp, 190-600 nm 
Hardware Macintosh Performance 630 
HPLC apparatus 
Software Rainin Dynamax 
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The HPLC column used in this work was a reversed phase column filled with 
endcapped octadecyl silylated silica gel (RP-18 or C-18), thus a very unpolar 
stationary phase. Specific characteristic of endcappings are stable chemical 
groups to protect the reversed phase material from tiredness. Separation is 
performed by polarity; in contrast to normal phase chromatography polar 
compound elute first, unpolar substances are retained by the stationary phase. It 
also can be observed that small compounds elute earlier than big, bulky 
molecules. Dimensions of the column used were 250 mm in length and 4 mm in 
inner diameter.  
The sample was prepared by weighting 5 mg of each fraction into an Eppendorf 
tube and dissolved in 1000 Ol methanol by using sonar. Then the solution was 
filtered using a Rotilabo tm PTFE pore size 0.45 Om syringe filter ROTH into a new 
Eppendorf tube. 20 Ol of sample solution was injected. 
 
2.2.2.2.3   HPLC of the active compounds 
HPLC was done to the fractions out of 11-17 (1,2,3,4-6,7-14 crystal,7-14 
standard,15-20, 21-25,26-28, 29-33). At the beginning several solvents were 
tested on fraction 26-28 since this fraction is with most different components 
showing UV-absorbance. The solvent systems proved were isocratic and gradient 
systems e.g. water-methanol and formic acid-methanol. Different wavelengths also 
were tested e.g. 210 nm, 254 nm, 360 nm, 430 nm. 
One signal was found occurring in most fractions. This signal is shown as a peak 
at retention time of 3.1 minute. Since the corresponding substance shows high 
absorbance activity at 254 nm maybe is a degradation product from chlorophylls. 
Chlorophyll and their degradation products are detectable with UV light of 254 nm. 
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It should be noted that the HPLC instruments used are highly sensitive and even 
traces of substances can be detected, shown as signals with small and very small 
peak areas. Using an isocratic system containing only methanol as an eluent and 
a wavelength of 254 nm for detection, one and in some fractions a second peak 
could be shown. Some fractions like 4-6 and 7-14-crystals did not show signals 
since there is no chromophor. 
 
2.2.3 Methods of Fractionation and Isolation 
2.2.3.1 Liquid –liquid separation  
2625 grams of fresh Allium ursinum leaves were blended in 3600 ml ethanol 96% 
using an ultraturrax T50 (Janke &Kunkel). The mixture was let for maceration for 
12 hours at room temperature. After filtering maceration was repeated for 12 and 
24 hours, repectively. The combined ethanol solutions were dried in vacuo at 40°C 
bath temperature. The resulting dry extract was dissolved in 700 ml water and 
exhaustively extracted 3 times with 300 ml chloroform and subsequently 3 times 
with 300 ml ethyl acetate . The combined chloroformic phases were dried in vacuo 
at 40°C bath tempreture. The combined ethyl actetate phases and resulting 
aqueous phase were treated accordingly. The resulting extracts and the water 
residue were dried in vacuo and tested by several TLC: TLC on alliins/allicins fig. 
14, TLC on saponosides fig. 15, TLC on phenolic compounds fig. 16, general TLC 
fig. 17. 
All fractions were subjected to blood testing.fig 18. 
The yields are shown in Tab. 6. 
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Tab. 6: Yields of the dry extracts from 2625 g fresh Allium ursinum leaves 
Ethanol  
(whole extract) 
Chloroform Ethyl acetate Water 
177,00 g 28,70 g 1,02 g 146,20 g 
2.2.3.2 Column chromatography 
2.2.3.2.1 General Description 
Column chromatography is a method based on the same principles as TLC and 
can be used as analytical as well as preparative method. 
In pharmaceutical biology the gravity column chromatography is widely used for 
preparation of refined plant extracts and for the isolation of single compounds. For 
column chromatography a glass tube with tap is filled with the stationary phase, 
mostly silica gel. A reservoir containing the solvent should be put on the top. The 
mobile phase is pressed over the stationary phase only by gravitation. Compounds 
with low affinity to the solid phase and displaying many interactions with the mobile 
phase have low retention times: they elute early from column. Substances 
showing high affinity to the stationary phase elute late; they possess high retention 
times. The principle of column chromatography is shown in fig. (8.A). 
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Fig (8.A): principle of gravity column chromatography. 
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2.2.3.2.2 Column chromatography of the chloroform extract  
Since the chloroform extract (of step 2.2.3.1) displayed the highest 
antiaggregatory effect on platelets it was selected for further investigations. In the 
present work a normal phase gravity column chromatography was chosen for 
separation of the chloroform extract. Therefore 500 g of silica gel (particle size 
0.063 – 0.200) was elutriated in 1500 ml chloroform and filled into a glass column 
(length 32 cm, 5 cm in diameter). 25 g of the chloroform extract was dissolved in 
20 ml chloroform: methanol 95:5. Eluation was done with 3000 ml chloroform 
subsequently with 3000 ml chloroform : methanol 95:5, 3000 ml chloroform : 
methanol 9:1, 3500 ml chloroform : methanol 8:2, 1000 ml chloroform : methanol 
60:40, 1000 chloroform : methanol 50:30 and 2000 ml of methanol. Fraction size 
was 500 ml, 28 fractions were taken and analyzed by TLC. Fractions with similar 
characters were unified and dried in vacuo. The fractions obtained are shown 
below in table 7. 
 
Table (7): Fractions with yields 
fraction numbers yields [g] 
2 to   4 2,29 
6 to   7 0,32 
5 0,15 
8 to   9 0,51 
10 9,82 
11 to 17 4,87 
18 to 28 6,66 
An overview TLC for the fractions mentioned above was carried under similar 
conditions as described in chapter 3.3.2 fig 19 (TLC of the most active fraction 
2 Materials and Methods   
34
from chlroformic extract) and all fractions were subjected to blood testing (figure 
20). 
2.2.3.2 .3 Column chromatography of the most active fraction (11-17) 
As Fraction 11-17 was found to have the most antiplatelets aggregatory effect, the 
fraction 11-17 was fractionated again by repeated column chromatography. 
Therefore a glass column (36.5 cm in length, 4 cm in diameter) was prepared 
stuffing the outlet with cotton batting and a layer of sand. Then the column was 
filled with 200 g of silica gel (particle size 0.040 – 0.063) elutriated in ethyl acetate. 
The solid phase had a total volume of 460 ml. The solid phase was rinsed with 
1000 ml ethyl acetate. After that fraction No. 11-17 (4.87 g) was dissolved in 20 ml 
ethyl acetate and put on the column. Eluation was done with 5250 ml ethyl acetate 
followed by 500 ml ethyl acetate : methanol 8:2, 500 ml ethyl acetate : methanol 
6:4, 500 ml ethyl acetate : methanol 4:6, 500 ml ethyl acetate : methanol 2:8 and 
1000 ml methanol. Fraction size was 250 ml, 33 fractions were gained. Fractions 
were united in accordance to TLC results and dried in vacuo except fraction no. 7-
14. Fractions were gained as in table 8. 
 
Table (8): Fractions obtained from fraction 11-17 with yields 




4 to   6 2,230 
7 to 14 0,170 
15 to 20 0,038 
21 to 25 2,177 
26 to 28 0,038 
29 to 33 0,016 
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An overview TLC of the fractions mentioned above was carried under similar 
conditions as described in section 2.2.2.1.3 (TLC of saponosides), figure 21. 
All fractions out of 11-17 were subjected to blood testing figure 22. 
 
Fraction No. 7 – 14 was concentrated to a volume of 50 ml by in-vacuo rotation 
and let at a temperature of –16° C for twelve hours. The green solution showing 
greenish white precipitate was centrifuged using a speed of 4000 rpm at 4° C for 
15 min. The supernatant was reduced to a volume of 10 ml and let at –16° C for 
two days. The greenish white precipitate was treated as mentioned above. 
The white precipitates and the green supernatants were united and dried in vacuo, 
respectively: 
 
Fraction 7-14, green supernatant:        0.134 g 
Fraction 7-14, white pellet crystals:                      0.035 g 
All fractions out of 11-17 were submitted to HPLC separation. HPLC was carried 
out using a Rainin Dynamax TM HPLC system. 
 
2.2.3.2.3.1   Column chromatography of the most active fraction out of 11-17 
(fraction number 1) 
Blood testing showed fraction No.1 out of fraction 11-17 (step 2.2.3.2.3) as the 
most active fraction. Fraction No.1 was submitted to repeated column 
chromatography. Therefore a glass column (25 cm in length, 1.3 cm in diameter) 
was prepared stuffing the outlet with cotton batting and a layer of sand. Then the 
column was filled with 20 g of silica gel (particle size 0,040 – 0,063) elutriated in 
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chloroform. The solid phase had a total volume of 25 ml. The solid phase was 
rinsed wih 50 ml chloroform.  After that fraction No.1 (0,106 g) was dissolved in 2.5 
ml chloroform and put on the column.  Eluation was done with 250 ml chloroform, 
followed by 50 ml methanol. Fraction size was 6 ml, 42 fractions were gained; the 
methanolic eluate was taken as one fraction (end fraction). Fractions were united 
in accordance to TLC results and dried in vacuo. TLC was carried out on TLC 
sheets 10 x 10 cm using chloroform as solvent system. Fractions were obtained as 
shown in table 9. The effect of different stimuli for fraction 1 as well as dose 
response activity demonstrated by log EC50 was measured as shown in fig 24, fig 
25 and fig 26. 
 
Tab (9): fractions obtained from fraction 1 with yields 
fraction numbers yields [mg] 
1 – 2 2.0 
3 – 4 2.0 
5 – 7 31.0 
8 – 15  10.0 
16 – 18    4.0 
19 – 22    3.0 
23 – 42  13.0 
methanolic eluate 59.0 
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2.2.4 Methods of chemical identification, nuclear magnetic resonance (NMR) 
2.2.4.1.   Definition  
 NMR (nuclear magnetic resonance) techniques are used to elucidate the 
chemical structures of synthesized or natural compounds. The basic principle of 
this method is the deflection of atom kernels when subjected to strong magnetic 
fields. Like electrons every proton and neutron has a negative or a positive spin. 
Nuclei possessing an odd number of protons and neutrons have a magnetic 
moment, since their spin is not balanced. Isotopes with odd nuclei are i.e. 1H, 13C
and 15N. Subjected to a strong magnetic field, energetic differences will occur in 
these kernels; this phenomenon is called the Zeeman Effect. The neutrons and 
protons absorb the electromagnetic energy and radiate it back by a special 
frequency which is expressed by the signals showing the chemical shifts. This 
frequency of resonance, the Larmor frequency, is not the same for all atom 
kernels; it depends on the individual magnetic fields and atom weights of their 
neighbor atoms, so resonance is individual. Consequently, NMR is highly 
applicable for structural elucidation. 
In this project NMR spectrometry was carried out using a VARIAN GEMINI 300, 
substances were dissolved in deuterated pyridine and measured using magnetic 
fields of 300 MHz. 
 
2.2.4.2 NMR methods  
In our experiment the following NMR methods were carried out:  
1-1d 1H-NMR  
2-2d 1H-NMR (COSY)  
3- 13C-NMR including DEPT, HMBC and HMQC  
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2.2.4.2.1   1d 1H-NMR (one dimensional proton NMR) 
The 1d 1H-NMR is a one dimensional proton NMR. The positions of the protons 
describe the types of chemical shifts which appear in signals, the number is 
displayed by the peak areas shown as integrals. Three types of chemical shifts are 
known: the low field type chemical shift ranges from 0.8 to 4.8 ppm (0.8 up to 2.0 
ppm means methyl group proton, 2.0 up to 4.8 ppm methylene group proton); the 
intermediate chemical shift posses values about 5.0 ppm (hydroxyl group proton); 
the high field chemical shift reaches from 6.0 up to 9.0 ppm (double bond system 
proton). The spin-spin-couplings are described by the multiplicity of the signals. 
Couplings between protons will result in dublets, triplets, and quadrublets. Singlet 
describe coupling without splitting of signals. The coupling constant J which is 
measured in Hertz is used to express the distance between two proximate signals 
and differentiate between couplings across the bonds. 
 
2.2.4.2.2  2d-1H-NMR (COSY) 
The correlation spectroscopy (COSY) facilitates the analysis of correlations. It is a 
two-dimensional nuclear magnetic resonance and shows homonuclear 
correlations between protons. These spin-spin couplings result from the bound 
electrons forming characteristic interactions to a nuclear spin. The resulting 
spectrum displays the signals as contour lines like on a map. The spectrum shows 
a diagonal formed by peaks. Non diagonal peaks are defined as cross peaks; they 
indicate the spin-spin coupling of the protons.  By matching the centers of the 
cross peaks together with each of the two related peaks, coupling of neighbored 
protons can be indetified.  
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2.2.4.2.3 1d-13C-NMR 
1d-13C-NMR is a one-dimensional carbon NMR. This method demands stronger 
magnetic fields and a higher amount of sample, since the 13C-isotope occurs rarely 
in nature. Signals are displayed in ranges from 10 up to 200 ppm. Similar to the 
proton spectra, there are characteristic high field and low field chemical shifts. 
Whereas -13CH3-signals occur with 15 up to 25 ppm, 13CH2-signals are found 
about 30 ppm and 13CH-signals about 70 ppm. 13C=13CH3-signals show chemical 
shifts about 115 up to 120 ppm, 13C=O-signals occur from 160 up to 205 ppm. 
 
2.2.4.2.3.1  DEPT (Distortionless Enhancement by Polarization Transfer) 
DEPT is used to differentiate the types of carbon atoms. It is more sensitive than 
1d-13C-NMR because of its ability in polarization transfer. The method of choice is 
DEPT-135. The number indicates the flip angle of the editing proton pulse in the 
sequence. 13CH3-groups and 13CH-groups show positive signals, 13CH2-groups 
show negative signals. The quarternary carbons display no signal. 
 
2.2.4.2.3.2   HSQC (Heteronuclear Single Quantum Coherence)  
HSQC is a two-dimensional method to display the chemical shifts of two different 
nuclei coupling with another. The mechanism of action is application of one 90-
degree pulse to the proton so as to see their chemical shift. By application of the 
second pulse to both proton and carbon, the chemical shift of protons will affect 
carbon magnetization as it is transferred from proton to carbon. Thus in HSQC 
spectra only signals of directly connected nuclei are recorded. 1H-13C-HSQC is a 
favorite method for structure elucidation of complex organic compounds. HSQC 
sometimes can be used to elucidate the anomeric systems of heteroglycosides. 
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2.2.4.2.3.3  HMBC (Heteronuclear Multible Bond Coherence) 
HMBC is a two-dimensional heteronuclear method similar to HMQC. In the 
opposite, HMQC correlations of several bonds are shown in the respective 
spectra. In 1H-13C-HMBC spectra usually display correlations over two to three 
bonds. 
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2.3   Materials and methods used in blood testing 
2.3.1   Materials:         
2.3.1.1 Chemical materials: 
1. ADP: moelab GmbH 
2. Collagen: moelab GmbH 
3. Arachidonic acid: moelab GmbH 
4. A23178: moelab GmbH 
5. Epinephrine: moelab GmbH 
 
2.3.1.2 Solutions: 
1. CaCl2: Carl Roth GmbH + CO.KG 
2. PBS:    
1- NaCl(8:00 gm), Carl Roth GmbH + CO.KG 
2- KCl (0.20gm), Merck KGaA 
3- Na2HPO4 (1.15gm) Merck KGaA 
4- KH2PO4 :( 0.20gm) Riedel-de Haen. 
 3. DMSO (dimethylsulfoxide): Carl Roth GmbH + CO.KG 
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2.3.1.3   Equipment and Devices  
2.3.1.3.1   Blood centrifigation device 
5 ml blood was taken from six volunteers, respectively. These blood samples were 
centrifuged at 150 rpm for 15 minutes to obtain platelet rich plasma, followed by a 
second centrifugation (1500 rpm, 15 minutes) for obtaining the platelets poor 
plasma (used as blank value). 
 
2.3.1.3.2 Platelets count device 
After centrifusion of the plasma in order to get platelets rich plasma, the blood of 
every volunteer should be tested for its platelets count before examining the 
aggregation profile. The normal platelets count is between 150,000-450,000 
platelets in each microliter of blood. 
2.3.1.3.3 Platelets aggregation profiler 
The PAP-4 is a four chanel aggregometer based on the turbidimetric method.The 
principle, platelets are stirred and light transmission is measured. Upon activation 
platelets start to form pseudopodia thereby transiently reducing light transmission 
thereafter, platelets aggregate and move to the bottom of the cuvatte this allowing 
higher light transmission. By measuring the transmitted light this process of 
platelets aggregation can be monitored. 
2.3.2 Methods of measuring platelets aggregation and the inhibitory activity 
of the extracts 
2.3.2.1   In-vitro examination 
The extracts were examined in-vitro in blood samples of six healthy volunteers of 
both gender aged between 25 and 35 years. The same candidates were used as 
controls and for garlic testing. 
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2.3.2.2. Platelet aggregation 
Citrated blood samples were centrifuged at 150 rpm for 15 minutes to obtain 
platelet rich plasma, followed by a second centrifugation (1500 rpm, 15 minutes) 
for obtaining the platelet poor plasma (used as blank value). The plasma was pre-
incubated with CaCl2 (1 mm) for 5 minutes. Dissolved garlic extract was prepared 
using a stock solution of 5 mg/ml Allium extract with 1 ml of PBS (phosphate 
buffered solution pH 6). In the next step 50 Ol of the stock solution was incubated 
with 450 ml of platelet rich plasma for 5 minutes. Platelet aggregation was then 
measured in a four-channel aggregometer (PAP-4 moeLab™, Berlin, Germany), 
using the turbidimetric method, according to the manufacturers manual. After 
preincubation for 5 minutes at 37° C, platelets were stimulated by addition of: 
 
1. ADP (20 OM): ADP is a lyophilized preparation of adenosine-5-diphosphate. 
The working concentration of reconstituted reagent is 20 OM. When added to 
platelets rich plasma, ADP stimulates platelets to change their shape and 
aggregate. Aggregation induced by exogenous ADP is referred to as primary 
aggregation and is reversible. Normal platelets will further respond by 
releasing endogenous ADP from their granules. Release of endogenous ADP 
produces a secondary wave of aggregation, which is reversible. 
2. ARA (0.5 mg/ml): Arachidonic acid is a lyophilized preparation of sodium 
arachidonate. The working concentration of the reagent is 5mg/ml. ARA is a 
fatty acid present in the granules and membranes of the human platelets. It is 
liberated from the phospholipids and in the presence of the enzyme cyclo-
oxygenase, incorporates oxygen to form the endoperoxide prostaglandin G2 
(PGG2). In vitro addition of ARA to normal platelets rich plasma results in a 
2 Materials and Methods   
44
burst of oxygen consumption, thromboxane formation and platelets 
aggregation. However in the presence of Aspirin or Aspirin containing 
compounds, these reactions are abscent. 
3. Collagen (0.19 mg/ml): Collagen is a lyophilized soluble calf skin collagen. The 
working concentration of the reagent is 1.9 mg/ml. When collagen is added to 
the platelet rich plasma, the platelets adhere to the collagen. Following the 
adhesion, normal platelets will change their shape, release endogenous ADP, 
and aggregate. 
4. A23178 (4 Og/ml) 
5. Epinephrine (20 OM): Epinephrine is a lyophilized preparation of adrenaline. 
The working concentration of the reconstituted reagent is (20 OM). When 
added to platelets rich plasma, epinephrine stimulates platelets to aggregate. 
Aggregation induced by epinephrine is referred as primary aggregation. 
Normal platelets will further respond by releasing endogenous ADP from their 
granules. Release of endogenous ADP results in a secondary wave of 
aggregation. 
Since the results revealed  that garlic extracts act on a specific pathway (ADP 
indueced aggregation) we investigated the concentration–response curve for the 
Allium sativum and Allium ursinum extracts at 5 mg/ml, 3 mg/ml, 2 mg/ml, 1 mg/ml, 
0.5 mg/ml, 0.2 mg/ml, 0.1 mg/ml and 0.02 mg/ml. 
Different Allium ursinum ethanolic extracts and subsequent chloroform fractions 
were examined on blood platelets as the same above mentioned procedure using 
ADP as a stimiulant to see their inhibitory action in order to elucidate the chemical 
entity of the effective compound. 
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3. Results  
3.1 Platelets antiaggregation effect 
Aim of the present work was to investigate the platelet aggregation inhibiting 
potential of Allium ursinum. Substances with well-established mechanisms of 
aggregation were employed for comparison, i.e. ADP, collagen and epinephrine. 
Further, the wild garlic (Allium ursinum) leaves were used to compare with the 
bulbs of common garlic (Allii sativi bulbus Ph. Eur.). There is a monography in the 
Pharmacopoea europaea for common garlic bulb powder, and effects of this drug 
are well-investigated. In the present experiment isolation and structure elucidation 
of the biological active components also had to be done.
3.1.1 Effects of common Garlic (alcoholic extract of Allium sativum [2.2.1.1])
on platelets aggregation and it’s mechanism of action 
Platelet rich plasma (PRP) of healthy volunteers was obtained and yielded platelet 
counts of 100.000 -150.000 platelets / µl in the platelet rich plasma. 
The PRP was stimulated by ADP (20 OM), collagen (0.19 mg/ml), ARA (0.5 
mg/ml), A23187 (4 Og/ml), epinephrine (20 OM). Figure 9 demonstrates a normal 
reaction after induction with the different stimuli resulting in aggregation of more 
than 50% (baseline). After preincubation of PRP with the alcoholic extract of Allium 
sativum platelet aggregation was significantly suppressed (garlic treatment), 
especially in the ADP mediated pathway. 
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Fig (9): Platelet aggregation determined by LTA (light transmission 
aggregometry) in platelet rich human plasma (n = 6 healthy individuals) at 
baseline and after incubation with alcoholic garlic extract from Allium 
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3.1.2 Testing of the aqueous and methanolic extracts (comparison of wild 
garlic to common garlic) 
For general testing if whether Allium ursinum has any antiplatelets activity 
comparable to common garlic aqueous and methanolic extracts were gained 
from Allium ursinum fresh leaves and they were prepared as described in 
chapter 2.2.1.1 and aqueous and methanolic extract were prepared as well for 
Allium sativum bulbs. In the present work two different TLCs for common garlic 
and wild garlic were done in order to compare the whole extracts of both plant 
drugs in respect of their chemical composition. Therefore two groups of 
compounds with known bioactivity were chosen: the alliins and allicins and 
their by-products were investigated (figure 10) as well as the saponoside 
pattern (figure 11).  
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Fig (10): TLC on alliins (reddish pink) and allicins (orange) in the garlic and 
wild garlic whole extracts, developed in the solvent system butanol: acetic 
acid: water 60:40:20, sprayed with ninhydrine solvent. 1 = aqueous extract 
from garlic bulbs, 2 = methanolic extract of garlic bulbs, 3 = commercial 
aqueous extract from garlic bulbs (20 µl), 4 = commercial aqueous extract 
from garlic bulbs (30 µl), 5 = aqueous extract from wild  garlic leaves, 6 = 
methanolic extract from wild garlic leaves, R = alanine (marker).  
3 Results  
49
Fig (11): TLC on saponosides in the common garlic and wild garlic whole 
extracts, developed in the solvent system chloroform: methanol: water 
60:40:10, after spraying with anisaldehyde reagent and heating. 1 = aqueous 
extract from garlic bulbs (20 µl), 2 = aqueous extract from garlic bulbs (30 
µl), 3 = aqueous extract from garlic bulbs (40 µl), 4 = aqueous extract from 
wild garlic leaves (20 µl), 5 = aqueous extract from wild garlic leaves (30 µl), 
6 = methanolic extract from wild garlic leaves (30 µl), R = desglucoruscoside 
(marker).  
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In comparison to common garlic bulb extracts the methanolic and aqueous 
extracts of wild garlic leaves showed some accordance in occurrence of natural 
compounds like the cysteinsulfoxides and their derivatives. Analysis by TLC 
exhibited a lower concentration of alliin in wild garlic in comparison to common 
garlic. Moreove, in wild garlic the content of allicin seems to be higher. The 
methanolic extracts of both, common garlic and wild garlic had a higher total 
amount of components than the aqueous extracts. This result is contrary to the 
expectance of a higher alliin / allicin content in the aqueous extract, since allicin is 
formed by enzymatic alliin degradation. Maybe extraction power of methanol was 
higher than the effectivity of water. However, allicin is formed by any injury of the 
plant cell, thus bringing out high contents allicin by comminution of plant material. 
The alliin / allicin pattern of wild garlic exhibits only slight differences in the 
contents of the different alliins (figure 10). The reddish pink alliine spots show a 
similar Rf range like the red spot of alanin. Other alliins are shown as red and pink 
spots above the alliin spot. The orange spots below alliin are considered to be 
allicin. Concerning the saponosides wild garlic shows a pattern similar to common 
garlic, whereas the methanolic extract exhibited a higher concentration of 
saponosides than the aqueous extracts. As shown in figure (11), the saponosides 
appear as greenish to grey blue spots with Rf range of 0.25 and 0.35 as well as 
0.62, the desglucoruscoside shows greenish spots at Rf 0.5. In comparison with 
the desglucoruscoside having three monosaccharide residues, it can be assumed 
that the main saponosides possess two (Rf 0.62), four (Rf 0.35) and five (Rf 0.25) 
monosaccharide residues. Saponosides with correlative structures are described 
by (Dini et al. 2005 [77], Carotenuto et al. 1999 [78] and Kawashima et al. 1993 
[79]). 
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3.1.3 Allium ursinum effect on Platelet aggregation (extract method 2.2.1.1) 
To examine the effect of Allium ursinum on platelet aggregation, PRP from the 
same volunteers was incubated with either an aqueous extract of Allium ursinum 
(light grey) or an alcoholic extract (dark grey) and compared to baseline values 
using different stimuli (Figure 12). The aqueous extract exhibited an unspecific 
effect on platelet aggregation independently from the stimulus which was used, 
thus, suggesting an unspecific effect rather than specific pharmacological 
interaction in the aggregation process itself. In contrast, the alcoholic extract of 
Allium ursinum affected platelet aggregation only in the ADP and to a lesser extent 
in the ARA and epinephrine pathway. These results would be in contradiction to 
earlier works on Allium Sativum (Mohammad and Woodward 1986 [80], 
Liakopoulou-Kyriakides 1984 [81]) with the findings of allicin as the main 
aggregation inhibiting compound; but in accordance to (Manaster et al. 2009 [82] 
)describing the mechanism of allicin reaction, indicating the antiaggregatory effect 
seen here might be caused by other substances. 
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Fig (12): Platelet aggregation determined by LTA in platelet rich human 
plasma (n=6 healthy individuals) at baseline and after incubation with 
aqueous extracts or alcoholic extracts of Allium ursinum (5 mg/ml) method 
chapter 2.2.1.1. * p<0.05 baseline versus aqueous extract. #   p<0.05 baseline 
versus alcoholic extract. 
 
.
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3.1.4 Concentration response curve for Allium sativum and Allium ursinum 
(methanolic extracts 2.2.1.1) 
After it had become obvious that garlic extracts act on ADP-induced aggregation, 
we investigated the concentration response curve for the Allium sativum and 
Allium ursinum extracts using 5 mg/ml, 3 mg/ml, 2 mg/ml, 1 mg/ml, 0.5 mg/ml, 0.2 
mg/ml, 0.1 mg/ml and 0.02 mg/ml. 
 Statistical Analysis: Statistical analysis was performed using SPSS statistical 
software (SPSS v.10.0.7; Chicago, IL, USA). Continuous data are presented as 
mean ± SEM. For comparison of continuous data T-test or Mann-Whitney-test (if 
normality failed) was utilized. The concentration response curve was analysed and 
fitted using GraphPadPrism (Vers. 4; GraphPad Software Inc., San Diego, USA). 
Concentration-response relationship regarding inhibition of ADP-induced platelet 
aggregation for the alcoholic wild garlic (Allium ursinum) extract was studied in 
comparison to the alcoholic Allium sativum extract, and revealed a clear sigmoid 
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3.2 Fractionation of the alcoholic (ethanolic) extract from wild garlic leaves 
(method chapter 2.2.3.1) 
As the alcoholic extract was found to exhibit a specific antiplatelets activity by 
inhibition of the ADP, it was chosen for further fractionation. 
Liquid-liquid fractionation of the ethanolic extract yielded several phases: 
chloroform phase, an ethyl acetate phase and a resulting aqueous phase. The 
volatile oil fraction was achieved by steam distillation of the fresh herb. This 
fractionation allowed a separation of the compounds into an unpolar (chloroform), 
middle polar (ethyl acetate) and polar group (water). 
 
3.2.1 TLCs of the ethanolic extract of wild garlic  
Separation of the different groups of components was achieved by liquid-liquid 
fractionation of the ethanolic extract from wild garlic leaves. As shown in figure 14, 
TLC analysis on alliins and allicins indicated the occurrence of these substances 
only in the aqueous phase, whereas the ethyl acetate extract and the chloroformic 
extract did not contain any of the cysteinsulfoxides or derivatives. Figure 15 shows 
that saponosides with greater glycoside residues are accumulated in the aqueous 
phase, visualized as brownish spots with Rf ranges 0.1 up to 0.2. In the ethyl 
acetate extract some weak violet spots with Rf ranges of 0.6 and 0.7 appeared, 
these spots seem to be triterpenes, phytosterols or saponosides with short 
glycoside residues or aglycones. These violet spots are found in the chloroform 
extract in very high concentrations beside carotinoids and chlorophylls (Rf ranges 
0.9 to 1.0). In TLC analysis of phenolic compounds (fig 16) flavons and flavonols 
were visualized as ultraviolet erasing (254 nm) spots showing orange 
fluorescence; proanthocyanidins were detected as ultraviolet erasing spots. TLC 
was sprayed with vanillin-sulfuric acid reagent. After heating at 110° C for 10 min 
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flavonols and flavons were shown as deep yellow spots, proanthocyanidins were 
visualized as intensive red spots. A “general” TLC (figure 17) showed the 
occurrence of rather polar flavonoids in the aqueous phase, visualized as an 
ultraviolet erasing (254 nm) spot with Rf range of 0.5, fluorescent in orange and of 
yellow colour after spraying. Another, a less polar flavonoid of Rf 0.7 was found in 
the ethyl acetate extract.  
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Fig. 14: TLC on alliins and allicins in the wild garlic extracts fractions, 
developed in the solvent system butanol: acetic acid: water 60:40:20, 
sprayed with ninhydrine solvent. 1 = ethanolic extract (20 µl), 2 = aqueous 
phase (20 µl), 3 = ethyl acetate extract (20 µl), 4 = chloroformic extract (20 
µl), 5 = ethanolic extract (30 µl), R = alanin (marker). 
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Fig (15): TLC on saponosides in the wild garlic extracts developed in the 
solvent system chloroform: methanol: water 60:40:10, after spraying with 
anisaldehyde reagent and heating. 1, 5 = ethanolic extract (10 µl), 2 = 
aqueous phase (20 µl), 3 = ethyl acetate extract (20 µl), 4 = chloroformic 
extract (20 µl), R = desglucoruscoside (marker).  
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Fig (16): TLC on phenolic compounds in the wild garlic extracts fractions 
developed in the solvent system ethyl acetate: methanol: water 77:13:10, 
after spraying with vanillin-sulfuric acid reagent and heating. 1, 5 = ethanolic 
extract (20 µl), 2 = aqueous phase (20 µl), 3 = ethyl acetate extract (20 µl), 4 = 
chloroformic extract (20 µl), R = hyperoside and rutin (marker). 
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Fig (17): “general” TLC of the wild garlic extracts, developed in the solvent 
system chloroform: methanol: water 60:40:10, after spraying with vanillin-
sulfuric acid reagent and heating. 1 = ethanolic extract (20 µl), 2 = aqueous 
phase (10 µl), 3 = ethyl acetate extract (20 µl), 4 = chloroformic extract (20 
µl), 5 = ethanolic extract (10 µl), R = alanin (marker), R = desglucoruscoside 
(marker). 
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3.2.2 The results of antiplatelets aggregation of the four ethanolic Allium 
ursinum extracts (method chapter 2.2.3.1) 
 Four different extracts of Allium ursinum (chloroform phase, ethyl acetate phase, 
water phase as well as the essential oil) of the ethanolic extract were subjected to 
blood testing to investigate their effects on rates of platelets aggregation. It was 
clear that the ethyl acetate phase is the most potent form followed by the 
chloroform extract and to a lesser extent the oily phase. As unexpected, the water 
phase of the Ethanolic did not have any role in preventing platelets aggregation, 
as illustrated in figure 18. By reason of the small amount of ethyl acetate extract 
and high yield of chloroform phase, the latter was taken for further investigations. 
 
Fig (18):  Effect of different extracts of Allium ursinum (methods 2.2.3.1) on 
the rates of platelets aggregation, the control group: platelet rich plasma 
without Allium ursinum treatment, stimulated with 20SM ADP. 
Allium ursinum different extracts effect on platelets 
aggregation



















































































3 Results  
61
3.3 Separartion of the chloroform extract  
3.3.1 Column chromatography for the chloroform extract of alcoholic Allium 
ursinum raw extract 
The chloroform extract was chosen for further examination due to its strong 
inhibitory activity and the high yield gained form the fresh herb. Thus it was 
subjected to gravity column chromatography for further fractionation which 
resulted in 28 fractions. Fractions were united according analogies in pattern 
achieved by TLC analysis as shown in table 7 chapter (2.2.3.2.2) and dried in 
vacuo. 
 
3.3.2 TLC of the most active fraction from chloroformic extract (method 
chapter 2.2.3.2.3) 
Analysis of the active fractions by TLC evidenced the most active fraction 11-17 
containing a high concentration of substances showing violet spots with Rf range 
about 0.7 beside carotinoids and chlorophylls, as presented in figure 19. The less 
active fraction 10 showed high concentrations of chlorophylls and two spots, a red 
spot (Rf 0.88) and deep violet spot at Rf 0.69, but in a much lower concentration. 
Fraction 18-28, the fraction that exhibited no activity at all, showed a pattern 
related to that of 11-17, but the spots with Rf values of 0.88 and 0.69 were absent. 
So it is to assume that one of the substances showing an intensive red spot (Rf 
0.88) and an intensive violet spot (Rf 0.69) is the active one. 
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Fig (19): TLC on the fractions of the chloroform extract developed in the 
solvent system chloroform: methanol: water 60:40:10, after spraying with 
anisaldehyde reagent and heating. 1 = fractions 8-9, 2 = fraction 10, 3= 
fractions 11-17 (10 µl), 4 = fractions 11-17 (20 µl), 5 = fractions 11-17 (30 µl), 6 
= fractions 18-28, R = desglucoruscoside (marker). The most active fraction 
is 11-17, which contains chlorophylls (Rf range 0,91 and 0,98, green in VIS), 
carotinoids (0,96 and 0,9, yellow to orange in VIS) and spots presumably 
saponosides (Rf ranges 0,62, 0,69, 0,72, 0,78 and 0,88; after spraying and 
heating violet and reddish violet in VIS). Fraction 18-28 also shows violet 
spots with Rf ranges 0, 59, 0, 72 and 0, 78 . 
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3.3.3 Antiplatelets aggregatory effect for the chloroform fractions of Allium 
ursinum 
As shown in figure 20, fraction 11-17 showed the highest Antiplatelets activity. 
Fig (20):  Different chlroformic fractions and their effects on platelets 
aggregation (method chapter 2.2.3.2.2), the control group: platelet rich 
plasma without Allium ursinum treatment, stimulated with 20SM ADP. 
 
3.4 Column chromatography for fraction 11-17 
As fraction 11-17 was found to have the most antiplatelets aggregatory effect, the 
fraction 11-17 was fractionated again by repeated column chromatography, and as 
a result 33 fractions were gained. Fractions were united in accordance to TLC 
results and dried in vacuo except fraction no. 7-14. Since the latter fraction 
showed clouding spontaneously, it was separated by precipitation in cold followed 
by centrifugation in order to obtain a greenish supernatant (11-17/7-14 SN) and a 
white crystalline pellet, marked as (11-17/7-14 crystal). 
Chloroform  Fractions of  Allium ursinum  and their effect on 
rates of platelets aggregations 
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3.4.1 TLC for fractions obtained from fraction 11-17 
 An overview TLC of the fractions gained from 11-17 was carried out as shown in 
the below figure 21 using similar conditions as described in chapter 2.2.2.1.3     
(TLC detection method of saponosides). 
 
Fig (21):  TLC for 11-17 subfractions (method of fractionation, chapter 
2.2.3.2.3). 
 
3.4.2 Antiplatelets aggregatory effects for the 11-17 subfractions 
Finally ten different subfractions were examined in order to detect the most potent 
forms that prevent platelets aggregation. It was clear that all the subfractions have 
an obvious antiplatelets activity but with different rates (figure 22). Obviously 
subfraction1, subfraction 4-6, subfraction 15-20, subfraction 7-14 precipitate have 
the greatest effects with a percentage of platelets aggregation remained of less 
than 5 %. Although subtractions 21-25, 26-28, 29-33 have much less effect, still 
they inhibited the aggregation by less than 84%.  
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Alium Ursinum 11-17 subfractions and their effect on rates of platelets 
aggregations





























Fig (22):  The final 10 subfractions and their antiplatelets activity (method 
chapter 2.2.3.2.3), the control group: platelet rich plasma without Allium 
ursinum treatment, stimulated with 20SM ADP. 
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All steps that lead from plant material to the subfractions decribed above are 
demonstrated in the working scheme shown in figure 23. 
Fresh Allium ursinum leaves 
2625 g 
Extraction: 
3 x 3600 ml Ethanol, RT 
Ethanolic extract 
177.00 g 
Disolving in water 1000 ml 
Liquid-Liquid extraction 
1. 3 x 700 ml chloroform 
2. 3 x 700 ml ethyl acetate 
Aqueous phase 
146.20 g




Method     Results 
2.2.3.1      fig.18 




Gravity column chromatography 
Silica gel 60, 
chloroform : methanol  
fraction size 500 ml 
Fractions 1 – 28 
Fraction 11-17 
4,87 g 
Unifying according TLC 
Platelet aggregation assay 
Fractions 1- 33 
Fraction 11-17/7-14 
0,17 g 
Gravity column chromatography 
Silica gel 60, 
ethylacetate : methanol  










Fig (23): Obtained amounts of 
extracts and fractions and 
scheme of extraction and 
fractionation (in ovals the 
corresponding extraction methods 
section and the corresponding 




2.2.3.2.2     fig.20 
Method Results
2.2.3.23      fig.22 
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3.4.3 Dose response effect, Log EC50 for subfraction 1, 4-6, 7-14 crystal 
and15-20 (fractionation method chapter 2.2.3.2.3) 
As fractions 1, 4-6, 7-14 crystal, 15-20 showed the highest antiplatelets 
aggregatory effects among the last 10 subfractions. For these subfractions dose 
response activity was measured and utilized to log EC50. 
3.4.3.1 Effect of different stimuli on subfraction 1(extraction method chapter 
2.2.3.2.3) 
As subfraction 11-17/1 showed a high antaggregatory effect; dose response and 
effect of different stimuli (ADP, Collagen, ARA, and Epinephrine) were studied. 
CC 
 
Fig (24):  The effect of different stimuli on subfraction 11-17/1 of Allium 
ursinum.
This results match with our primary finding in thesis work which is that the ADP 
inhibition is the mechanism of action so as subfraction 11-17/1 exerts its effect. 
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Subfraction 11-
































The effect of different stimuli on subfraction 11-17/1 of Allium ursinum 
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3.4.3.2 Log EC 50 for the active subfractions 11-17/1, 4-6, 7-14 crys, 15-20 
(method chapter 2.2.3.2.3) 
Fig (25):  log (EC50) for different subfractions from 11-17(subfraction 11-
17/1: -1.09, subfraction 11-17/4-6:-1.129, subfraction 11-17/7-14 crystals: -
0.9587, subfraction 11-17/15-20: -0.9402). 
Fig (26):  log (EC50) for different final subfractions using calculation with 
variable Hill slope. Subfraction 11-17/1: -1.039; subfraction 11-17/4-6:-1.115; 
subfraction 11-17/7-14 crystals: -0.975; subfraction 11-17/15-20: -0.9595. 
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3.4.4 HPLC for 11-17 subfractions 
In order to compare the TLC results a HPLC method was developed for possible 
monitoring of bioactive and accompanying components in Allium ursinum 
preparations. At the beginning several solvents were tested on subfraction 11-
17/26-28 since this subfraction contained the most different components showing 
UV-absorbance. The solvent systems tested were isocratic or gradient systems 
e.g. water-methanol and formic acid 5%-methanol. Different wavelengths also 
were tested e.g. 210 nm, 254 nm, 360 nm, 430 nm. 
 A wavelength of 254 nm was found to be most applicable; this short wavelength is 
a “general” wavelength where small benzene systems show high absorbance 
which enables to detect all compounds containing this structural character. In fact 
a wavelength about 200 nm enables to detect structures without conjugated 
double bond systems and would fit to the active compounds found in the present 
work; using similar wavelengths, however, the solvent system showed 
unfavourabile signal-noise relations. 
One signal was found occurring in most fractions. This signal is shown as a peak 
at retention time of 3.1 minutes. Since the corresponding substance shows high 
absorbance activity at 254 nm it could be a phenolic compound i.e. like caffeic acid 
or a degradation product from chlorophyll. Chlorophyll and its degradation 
products are detectable with UV light of 254 nm. It should be noticed that the 
HPLC instruments used are highly sensitive and even traces of substances can be 
detected, shown as signals with small and very small peak areas. Using an 
isocratic system containing only methanol as an eluent and a wavelength of 254 
nm for detection, one peak and in some fractions a second peak could be found. 
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Some fractions like subfractions 11-17/4-6 and 11-17/7-14-crystals did not show 
signals. 
As shown in figure 27, subfraction 11-17/1 shows one peak but too small for 
computer assisted integration. This means that the concentration of the absorbing 
substance is very low. Subfraction 11-17/1 was a mixture of different components 
containing degradation products of chlorophylls which identified from the UV 
spectrum of the peaks. In subfraction 11-17/2 two peaks were observed with 
retention times of 3.1 minutes and 5.8 minutes respectively. The corresponding 
substances were in high concentrations as shown by high peak areas. 
 
Fig (27): HPL-chromatograms of subfraction 11-17/1 (left) and subfraction 11-
17/2 (right).  
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In subfraction 11-17/3 the main peak with 3.1 minutes is also observed, but with 
lower peak area. In subfraction 11-17/4-6 the main peak is observed together with 
another peak with retention time of 4.4 minutes; both peaks are not base-line 
separated. These peaks belong to contaminations in subfraction 11-17/4-6 that 
could not be detected in NMR, so impurity was not high. The concentration of the 
corresponding substances is very low confirmed by low peak area as shown in 
Figure 28. 
 
Fig (28): HPL-chromatograms of subfraction 11-17/3 (left) and subfraction 11-
17/4-6 (right) (254 nm). 
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Subfraction 11-17/7-14 (method chapter 2.2.3.2.3) was very poor in absorbent 
substances as shown in figure 29. In the supernatant there was a small signal 
showing absorbance and with very low peak area. The peak had a retention time 
of 3.2 minutes and might be the main peak. The corresponding crystals showed 
nearly no signal. As shown in figure 29, the signal is very small in comparison to 
the background noise. 
 
Fig (29): HPL-chromatograms for subfraction 11-17/7-14. The supernatant 
(left) and the corresponding crystals (right) show low absorbance intensity. 
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The following subfraction 11-17/15-20 (method chapter 2.2.3.2.3) again showed 
the main peak at retention time 3.2 minutes and a second peak at 7.2 minutes. 
The concentrations of the corresponding substances were high as shown by the 
high peak areas, as shown in figure 30. However subfraction 11-17/21-25 (method 
chapter 2.2.3.2.3) showed a very small peak with very small peak area. The peak 
seems to consist of at least three peaks. Maybe the absorbance was too low for 
exact measurement.     
 
Fig (30): HPL-chromatograms for subfraction 11-17/15-20 (left) and 
subfraction 11-17/21-25 (right) (254 nm). 
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The HPL-chromatograms for subfraction 11-17/26-28 and subfraction 11-17/29-33 
are shown in figure 31. Both fractions show the main peak at a retention time of 
3.1 minute with relatively high peak areas that means the corresponding 
substance exists in high concentration.  
 
Fig (31): HPL-chromatograms for subfraction 11-17/26-28 (left) and 
subfraction 11-17/29-33 (right) (254 nm). 
 
The peak at retention time of 3.1 min was partly found in the active subfractions. It 
imagines a compound absorbing in ranges of 254 nm; this means maybe a small 
phenolic compound being comparable polar. However, in respect to be chlorophyll 
or carotene degradation product, the according substance maybe found in all 
fractions accompanying the active principle. 
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3.5 Chemical identity of two isolated compounds 
According to TLC subfractions 11-17/4-6 and 11-17/7-14 crystal were shown to be 
compounds of comparative pureness. Hence structure elucidation was possible. 
For identification and structure elucidation of the components isolated in the 
present work mass spectrometry and NMR spectroscopy were used. Electrospray 
ionization mass spectrometry was chosen based on being a soft and sensitive 
method. Mass spectrometry was carried out on a BUKER DALTONICS 7 Tesla 
APEX II FT-ICR mass spectrometer. One and two dimensional proton and carbon-
13 NMR spectra confirmed the results from MS. Since relatively high amounts of 
the two compounds could be isolated in high purity, for NMR a VARIAN GEMINI 
300 was employed. 
 
3.5.1 Structure elucidation of subfraction 11-17/ 7-14 crystals 
The structure of subfraction 7-14-crystals was determined as N-sitosterol-3-O-N-D-
glucoside (Fig 32). Mass spectrometry was done using ESI-MS (Electrospray 
ionization-mass spectrometric) in negative mode. As shown in figure 33, the 
corresponding mass spectrometry graph showed two mass peaks of 575.43 atom 
mass units (amu) (M-H) and of 621 amu, respectively. Both masses seem to 
belong to the same molecule, while the mass peak of 621.43 amu might be 
together with the residue of formic acid, which was put to the solution to increase 
resolution of the substance. The exact mass is 576 amu. 














































Fig (32): Structure of subfraction 11-17/7-14-crystals: the compound 
determined as U-sitosterol-3-O-U-D-glucoside by ESI-MS and NMR. The 
numbers assign the positions of the carbons with their corresponding 
protons.  
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3.5.1.1 Mass spectrometry of subfraction 11-17/ 7-14 crystals 
Fig (33): ESI-MS mass spectrometry graph of subfraction 11-17/7-14 crystals 
in negative mode showing a mass peak of amu 575.43 (M-H). The mass peak 
of amu 621.43 maybe the same substance but together with formic acid. 
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3.5.1.2 NMR spectroscopy of subfraction 11-17/ 7-14 crystals 
NMR spectrometry was done using conventional magnetic fields (300 MHz). 
Deuterated pyridine was used as solvent. The structure was determined by using 
proton- (1H-) NMR and carbon-13- (13C-) NMR. An overview 1H-spectra showed 
signals from 0 to 3 ppm showing protons of saturated like CH2-groups and CH3-
groups (see figure 34 and figure 35). The proton signals between 0 and 1.2 ppm in 
majority belong to the aliphatic parts, the most of the signals ranging from 1,2 up 
to 3 ppm are cyclic protons. All these signals suggest a cholesterol-like aglycon 
part. Peaks in the range from 3.5 to 5.5 ppm show the chemical shifts of the 
glycoside regions, as shown in figure 36. Two signals showed downfield chemical 
shift: the chemical shift of 3.92 ppm showing to be the glycosidation position. 
COSY-1H-NMR provided that signals over 5.5 ppm do not couple with any other 
signal in the spectra and therefore these signals belong the solvent (see fig.35). 
The glycoside part was determined by a 1H-COSY spectrum as shown in figure 38. 
The glycoside was elucidated as glucose by the cross peaks of all protons in the 
glycoside moiety. All informations from 1H-spectrum imagined a N-sitosterol-3-O-
glucoside. 13C-spectra confirmed the structure. The 13C-chemical shift of 101.42 
ppm for position C-1’ in the glucose showed the corresponding glucose to be bond 
to a N-hydroxyl group. 
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Fig (34): 1H-NMR spectrometry graph of subfraction 11-17/7-14-crystals. This 
proton spectrum is an overview showing all chemical shifts from 0 to 10 
ppm (300 MHz, V, pyridine).  
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Fig (35): 1H-NMR spectrum of subfraction 11-17/7-14-crystals showing the 
aglycon part. The positions of the protons in the aglycon moiety are signed 
above the peaks of chemical shifts (300 MHz, V, pyridine). 
Fig (36): 1H-NMR spectrum of the sugar part of subfraction 11-17/7-14 
crystals. The positions of the protons in the sugar part are signed above the 
peaks of chemical shifts (300 MHz, V, pyridine). 
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Fig (37): 1H-COSY of part of  subfraction 11-17/7-14 crystals overview (above) 
and 1H-COSY of the corresponding aglycon part (below) (300 MHz, V,
pyridine). 
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Fig (38): 1H-COSY of the glycoside part of subfraction 11-17/7-14 crystals. 
The signals range between 3.5 up to 5.1 ppm; in which the glycoside 
positions are shown at the left side. The signal at 5.35 shows no coupling 
with another glycoside signal (300 MHz, V, pyridine).  
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Fig (39): 13C-chemical shifts of subfraction 11-17/7-14 crystals in the range 
from 0 to 80 ppm. The positions in the molecule are signed above the 
signals (300 MHz, V, pyridine). 
 
Fig (40): 13C-chemical shifts of subfraction 7-14 crystals in the range from 80 
to 200 ppm. The positions in the molecule are signed above the signals (300 
MHz, V, pyridine). 
3 Results  
85
3.5.2. Structure elucidation of subfraction 11-17/4-6  
3.5.2.1 Mass spectrometry of subfraction 11-17/4-6 
The structure of subfraction 11-17/4-6 was elucidated as a cerebroside-like 
molecule composed of glycerol with two residues of linolenic acid and one N-D-
galactose-residue (Figure 41). Mass spectrometry results were achieved using 
ESI-MS in positive mode. Mass spectrometry graph showed a mass of 797.52 
amu in positive mode using solution of sodium salts for resolvatation of the 
substance (see figure 42). This molecular weight showed the substance together 
with one or two sodium ions ([M+Na] and [M+2Na]). A second measurement using 
positive mode was done using ammonia salts for resolvatation showed a mass 
peak of 775.52 amu (M+H) as shown in figure 43. From these results the mass of 





































Fig (41): Subfraction 11-17/4-6, determined as 1-U-D-galactopyranoside-2, 3-
bis-linolenic glycerate. 
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Fig (42): mass spectrometry graph of subfraction 11-17/4-6 showing two 
mass peaks with 797.52 amu and 829.51 amu respectively. The 
corresponding substance is together with one and two sodium ions, 
respectively. Mass spectrometry was done using ESI-MS in positive mode.  
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Fig (43):  mass spectrometry graph of subfraction 11-17/4-6 showing the 
mass peak with 775.52 amu (M+H). Conditions: Mass spectrometry was done 
using ESI-MS in positive mode.  
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3.5.2.2   NMR spectroscopy for subfraction 11-17/4-6 
NMR spectrometry was done using a magnetic field of 300 MHz. As solvent 
deuterated methanol (CD3OD) was used. Figure 44 shows an overview illustrating 
that there are signals from 0 to 5.6 ppm and there is no chemical shift over 5.6 
ppm. This imagines a compound mainly possessing CH3-groups indicated by the 
shifts from 0.9 ppm up to 2.0 ppm as well as CH2-groups ranging from 2.0 up to 
3.0 ppm. 1H-chemical shifts ranging from 0 to 2,9 ppm indicated single bond 
aliphatic groups. As displayed in figure 45 the proton spectrum also showed CH-
groups in the range of 3.4 to 4.4 ppm belonging to a glycoside part. Saturated 
parts bond with hydroxyl groups and bulk molecule parts were found in the range 
of 4.4 to 5.5 ppm. Aliphatic groups possessing double bonds were shown in 
ranges from 5.3 to 5.5 ppm. These informations led to the assumption that the 
molecule consists of a glycoside part and fatty acid residues, which was confirmed 
by COSY as shown in figure 46. 
Figure 47 shows the 1H-COSY-NMR spectrum of the glycoside moiety.The 
couplings indicate that there is no glucose but another monosaccharide. Figure 48 
gives an overview spectrum of the 13C-NMR. The carbon-13-spectrum revealed 
two downfield shifts in the range of 173 ppm in which these signals belong to 
carbonyl groups in an aliphatic system. Signals in ranges of 120 up to 140 ppm 
showed aliphatic carbons with double bonds. Single bond aliphatic carbons are 
shown as signals in the range of 12 to 35 ppm. Peaks in the range of 60 to 75 ppm 
belong to the glycerol part and to the glycoside part, respectively. A signal at 104 
ppm is the signal of the C-1-position of the glycoside residue. Figure 49 gives the 
HMQC spectrum, which demonstrates the carbon binding to the corresponding 
proton. With this information the structure was determined as a cerebroside-like 
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substance based on glycerol, containing two linolenic acid residues on position 2 
and 3, and a N-D-galactose in position 1. The bindings between glycerol and 
linolenic acid residues were confirmed by using HMBC-NMR-spectroscopy.  
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Fig (44): overview proton spectrum of fraction 11-17/4-6 (300 MHz, V,
CD3OD). 
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Fig (45): proton spectrum of subfraction 11-17/4-6 (300 MHz, V, CD3OD). 
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Fig (46): overview 1H-NMR-COSY spectrum of subfraction 11-17/4-6 (300 
MHz, V, CD3OD). 
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Fig (47): 1H-NMR-COSY spectrum of the glycoside part of subfraction 11-
17/4-6 (300 MHz, V, CD3OD). 
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Fig (48): 13C-NMR spectrum (overview) of subfraction 11-17/4-6 (300 MHz, V,
CD3OD). 
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Fig (49): HMQC spectrum of subfraction 11-17/4-6 (300 MHz, V, CD3OD). This 
shows the correlation between protons and carbon atoms. 
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4. Discussion 
4.1 First Report 
To the best of our knowledge this is the first report describing an antiplatelet in-
vitro effect of Allium ursinum extracts with a predominant effect on ADP-induced 
aggregation. 
For the first time we report the exact mechanism by which Allium ursinum and 
Allium sativum prevent platelet aggregation. Figures 9 and 12 in the results of the 
antiplatelets activity demonstrate a mechanism in the ADP pathway. While the 
aqueous extract of Allium ursinum seems to act only unspecific, the alcoholic 
extract showed an antiaggregatory mechanism similar to Allium sativum with the 
ADP pathway as the main target as clinically known from clopidogrel. 
4.2 Dose-dependent effect  
Dose-dependent effects were evident in the action of both Allium ursinum and 
Allium sativum demonstrating a comparable potency of both extracts with EC50 
values around 0.1 mg/ml. In our experiment we have proven that both Allium 
ursinum and Allium sativum exerts the same antiaggregatory effect while other 
studies found that wild garlic may exert greater effects than common garlic on 
blood pressure and blood chemistry in rats: Allium ursinum produced significant 
higher decrease in systemic blood pressure at lower concentration compared to 
Allium sativum. Furthermore Allium ursinum significantly decrease total cholesterol 
and increased high density lipoproteins more than Allium sativum (Neil HAW et al 
.1996 [38]; Steiner M. 1996 [39]; Preuss HG 2001 [69]). 
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4.3 Common garlic antiaggregatory activity 
In this experiment similar to that of Rahman and Billington 2000 [87], we found a 
favourable effect of alcoholic extract on ADP-induced aggregation, so that strongly 
supports the assumption that –at least- this extracts effect involves ADP receptors. 
On the other hand several other reports have shown an antiaggregatory effect of 
diverse garlic extracts which was directed towards ADP- and collagen-induced 
aggregation, but also inhibited aggregation induced by other stimuli such as 
fibrinogen (Legnani et al. 1993 [83]; Apitz-Castro et al. 1994[84]; Steiner and Lin 
1998 [85]; Hiyasat et al. 2007[86]).  
 While two types of receptors have been recognized with a G protein–coupled 
character {Gq-linked P2Y(1) and Gi-linked P2Y12(AC)}  both being supposed to 
be involved in the platelets aggregation process, the high affinity for ADP is typical 
for the P2Y(1) receptor and a lower affinity for  the second receptor P2Y12(AC) 
(Takasaki et al. 2001 [88]). 
 Ajoene ((E, Z) 4,5,9-trithiadodeca-1,6,11-triene-9-oxide) is a synthetic derivative 
from alliin after alliinase activity which can block both ADP- and collagen-induced 
aggregation. This theory might partly explain the antiplatelet activity of garlic 
species (Teranishi et al. 2003 [89]). The S-allyl-Lcysteine sulfoxides, which are 
generated by the thermolabile enzyme alliinase is considered to be responsible for 
the antiaggregatory effect of Allium sativum (Lawson et al. 1992 [90]; Block 1992 
[51]).  
Alliinase should degrade alliine to produce the antiaggregatory effect so that 
crushing the garlic will increase this effect as it participates in releasing this 
enzyme. Moreover regarding the antiplatelets activity it was assumed that heating 
garlic will inactivate this enzyme before the active sulphur compounds are formed  
explaning some of the controversial in vivo findings with garlic (Cavagnaro et al. 
2007 [91]). 
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4.4 Allium ursinum and Allium sativum – similar components? 
Regarding the compounds found in Allium ursinum in comparison to Allium 
sativum our TLCs showed saponosides, alliins and allicins in similar patterns, and 
comparable amounts of allicins in the ethanolic wild garlic extract. The ethanolic 
extracts seemed to have generally higher contents of the components than the 
aqueous extracts. Thus, the similar pattern in antiaggregatory effects and the 
similar potency of both Allium sativum and Allium ursinum are in good accordance 
with similar patterns of the component groups as investigated by TLC. 
 
4.5 Active compounds in wild garlic 
The aim of the final steps of the study was to identify the active compounds in wild 
garlic. Therefore, primary fractionation of the alcoholic extract was performed. 
Against expectance, the aqueous phase containing the saponoside moiety and the 
sulphuric compounds like alliin, allicin and ajoene, showed only small unspecific 
activity, whereas the unpolar chloroform extract showed platelet antiaggregatory 
effects by antagonistic influence on ADP-induced aggregation. Since chloroform 
extract exhibited contents of chlorophylls, fatty acids and lipophilic components 
like steroids, this extract was subjected to a bioassay-guided fractionation. Finally 
four fractions were achieved exhibiting most platelet antiaggregatory activities: 
fractions 11-17/1, 11-17/4-6, 11-17/15-20 as well as the precipitate of fraction 11-
17/7-14(crystals), which seemed to contain the active principle (see figure 22,24). 
As fraction 11-17/4-6 and 11-17/7-14(crystals) showed to be pure substances 
further chemical characterization was done for these two substances. 
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4.5.1 Subfraction 11-17/4-6 
For 11-17/4-6 a cerebroside-like structure was found. This structure was 
determined as a diacylglyceride with N-D-galacose in position 1 and two linolenic 
acid residues in position 2 and 3, respectively (see figure 41). The ESI-MS 
spectrum done in negative mode displays two signals of 797.52 and 829.51 amu, 
respectively. Both masses belong to the same molecule, whereas the mass 
differences of 22 amu and 44 amu can be explained by the presence of sodium 
ions within the buffer system used to dissolve the substance (see figure 42). The 
exact mass of this compound is 774.53 amu. This 1-N-D-galactopyranoside-2,3-
bis-linolenic glycerate could be described (Poincelot 1976 [92]). We report this 
compound to be a natural component in wild garlic for the first time; moreover, the 
compound could be shown to possess antiaggregatory activity. The amphipolar 
structure imagines interactions of the compound and the platelet membranes; to 
our knowledge it is the first time the compound is described to contribute to 
platelet antiaggregation by involving the ADP-receptor. 
4.5.2 Precipitate of fraction 7-14 (11-17/7-14crystal) 
The structure of the precipitate of fraction 11-17/7-14 crystal was determined as N-
sitosterol-3-O-N-D-glucoside (figure 32). Mass spectrometry showed two mass 
peaks of 575.43 amu (M-H) and of 621.43 amu, respectively. Both masses seem 
to belong to the same molecule, while the mass peak of 621.43 amu might be 
together with the residue of formic acid, which was added to the solution to 
increase resolution of the substance. The exact mass is 576 amu. This compound 
N-sitosterol-3-O-N-D-glucoside is a common constituent found in plant material, 
mainly accompanied by its aglycone N-sitosterol. Similar to the structure above, 
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aglycone N-sitosterol is a structure with an unpolar part and a polar saccharide 
moiety. Moreover showing analogous structural characteristics in respect of 
membrane steroids, this compound could be considered to influence the platelet 
membrane systems. In the present work N-sitosterol-3-O-N-D-glucoside also is 
described to exert ADP antagonistic effects. These results indicate that in our 
experiment the platelet aggregation inhibiting compounds are lipophilic; 
furthermore these compounds are not derivatives of the alliin / allicin system. 
Similar compounds like 6-O-acyl-N-D-glucosyl-N-sitosterol (comparable to our 
sitosterol-3-O-N-D-glucoside) as well as 1,2-dilinolenoyl-3-galactosyl-glycerol, 
linolenoyloleoyl-3-N-galactosylglycerol and 1,2-dipalmitoyl-3-N-galactosyl-glycerol 
are described as cyclooxygenase (COX) inhibitors by Weil et al. 2005 [93]. 
Therefore the COX platelet aggregation model was not used directly in this work; 
the antiaggregation activity for the isolated compounds could be explained by their 
COX-inhibiting action. The COX enzyme system produces prostaglandins from 
arachidonic acid; prostaglandin G2 is transformed to thromboxane A2 which leads 
to platelet aggregation. The blockage of the COX enzyme system also is a 
strategy for platelet aggregation inhibition. A well known COX inhibitor is acetyl 
salicylic acid known for its antithrombic effects.However, as evident from figure 12 
the arachedonic acid induced aggregation also was significantly inhibited by Allium 
ursinum, which could be a COX-dependent effect of N-sitosterol according to the 
considerations above. 
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Fig (50): Cascade of platelet aggregation by some mediators 
Fig (51):   Model of the gpIII/gpII receptor on platelet (source ref [102]) 
This Figure shows the GPIIIa/GPIIb receptor.This receptor is presented by 
the platelets after they are activated by thromboxane, which is derived from 
arachidonic acid. This means that this receptor is strongly involved in 
platelet aggregation. 
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4.6 Allium species preparations and components  
Till now there are no commercial preparations for wild garlic available while so 
many are present for the common garlic. 
It is supposed that the way of powder production is through treating the bulbs with 
hot ethanol steam, then dried and powdered. The essential oil is gained by steam 
distillation after fermentation of the garlic bulbs in water. The oily macerates are 
gained by digestion of the bulbs with rape oil or colza oil by warming. The results 
of the present work showing two lipophilic compounds involved in platelet 
antiaggregatory effects of wild garlic would favour the application of oily extracts. 
4.6.1 Cysteine sulfoxides component of garlic 
Cysteine sulfoxides are components present in garlic. Alliines are the native 
cysteine sulfoxides which are transformed to thiosulfinates (allicin) by the action of 
the enzyme alliinase. 
Allicin has strong antimicrobiotic and antimycotic activities (Goncagul and Ayaz 
2010 [94]). Allicin itself is degraded to further products as diallylsulfides, 
diallyldisulfides and vinyldithiins. The figures 52 and 53 show the presence of 
alliins in common garlic and the alliin transformation pathway to different products. 
In our experiment the cystein sulfoxides were found in the aqueous phase after 
liquid-liquid separation of an ethanolic extract of Allium ursinum. This extract 
revealed about 50% aggregation inhibition, whereas the lipophilic extracts showed 
stronger inhibition. In respect to cystein sulfoxides the results described in 
literature were achieved by application of the pure, isolated compounds. Our 
results go together with these findings considering application of an extract 
containing cystein sulfoxides in addition to a part of various other, possibly inactive 
natural compounds. 















































































Fig (53): cleavage of alliin by the enzyme alliinase and following 
transformations to diallylsulfides, diallyldisulfides and ajoenes. Further 
products are the vinyldithiins. The way shown on the left illustrates the 
transformation of allicin by steam distillation (according to Block E 1985 
[95]). 
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4.6.2 Steroidal saponosides component of garlic  
A second group of well-investigated compounds in Allium species are the steroidal 
saponosides of the spirostanol type (i.e. eruboside B) and the furostanol type (i.e. 
protoeruboside B and sativoside B1) as described by (Peng et al. 1996 [96] and 
Mochizuki et al. 2004 [97]). Figure 54 and 55 shows some saponins common in 
garlic. With regard to the distinct glycoside residues (figure 54) these compounds 
possess high polar character and should be found in the aqueous phase. Put 
together with the finding of the aqueous phase having small antiaggregatory 
effects, it can be considered, that the saponosides described are not involved in 
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Fig (55): saponosides described in garlic (compare Ref [95], [96]) 
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4.7 Unpolar lipophilic compounds 
As shown in our work, the alliins, allicins and ajoenes are polar compounds 
occurring in the aqueous phase, whereas the active compounds we found to 
inhibit platelet aggregations were characteristized as unpolar compounds of the 
chloroformic phase. The aqueous phase showed significantly weaker activity 
comparing to the chloroform phase. Thus, our results do not support the main role 
for the alliin complex in antiaggregatory effects. Maybe the alliins and allicins have 
collateral activity and show synergistic effects in the Allium ursinum raw extract. As 
shown by TLC analysis, the alliins and allicins (as well as the saponosides) are 
constituents of the aqueous phase. In our experiment the aqueous phase (from 
the ethanolic raw extract ) showed the weakest platelet aggregation inhibition with 
about 50%, whereas the volatile oil fraction and the lipophilic extracts, the 
chloroform phase and the ethyl acetate phase, showed stronger inhibition. The 
main platelet antiaggregation inhibition is evident for more lipophilic compounds – 
in this work two of the bioactive compounds were isolated and characterized as N-
sitosterol and 1-monogalactosyl 2,3-dilinolenoylglyceride. The results of this work 
show a main part of antiaggregatory activity for a lipophilic fraction, and a much 
weaker activity of the alliin complex. Maybe the allin / allicin system provides a 
synergistic effect. 
According to our data, the aggregation inhibiting effects of the volatile oil gained 
after alliin degradation would support the antiaggregatory effect of the diallyl 
sulphides and vinyldithiins. The mentioned components are well-known 
constituents of the volatile oil fraction of garlic, so that the volatile fraction of wild 
garlic could be compared with. These volatile compounds fraction was subjected 
to the platelet aggregation test system and showed the most efficient inhibition of 
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platelet aggregation (80%-90%). The amount achieved was very small and in 
range of some milligrams. For achieving fractions and subsequent isolation of 
bioactive compounds, an amount of the volatile oil in ranges of at least five grams 
would be required. 
4.8 New approaches and new results of this work 
In this work, ethanolic and aqueous extracts from wild garlic and common garlic 
were compared by analytical methods and in a bioassay system. All extracts 
showed platelet antiaggregatory activity, in which the alcoholic extracts – as stated 
above- showed higher activities than the aqueous extracts. Furthermore, the wild 
garlic methanolic extract showed higher activity than the common garlic 
methanolic extract. Based on these results, in our experiment an ethanolic extract 
was made followed by liquid-liquid fractionation. The resulting extracts were a 
chloroform phase, an ethyl acetate phase and a resulting aqueous phase. The 
volatile oil fraction was achieved by steam distillation of the fresh herb according 
Ph.Eur. Subjected to the platelet aggregation test system, the ethyl acetate phase 
showed the strongest inhibitory effects towards platelet aggregation, the inhibitory 
effect of the essential oil phase and the chloroform phase were shown as slightly 
weaker as the volatile oil fraction, but they also developed a very strong inhibition 
of platelet aggregation. Compared to the activity of these lipophilic extracts, the 
aqueous phase showed weak inhibitory effects. 
These findings are not exactly in accordance to the most publications where the 
group of the hydrophilic alliin and allicin derivatives are mentioned as the platelet 
antiaggregatory active components as well as the saponosides described in 
literature (Bordia 1978 [37]). 
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In our experiment the chloroform extract was chosen for further examinations due 
to its strong inhibitory activity and the high yield gained from the fresh herb. This 
extract was subjected to gravity column chromatography for further fractionation. 
The resulting fractions again were subjected to the platelet test system in order to 
isolate the active principles of the chloroform extract. The fraction 11-17 showed 
the main activity; compared to the whole chloroform extract. TLC comparison 
showed this fraction containing a mixture of predominantly lipophilic compounds. 
This fraction was subjected to separation by a second gravity column 
chromatography. Thereby four fractions showing intense antiagrregatory effects 
were afforded. In case of 11-17/7-14 crystals the structure of this compound 
isolated was elucidated by using ESI mass spectrometry and 1d/2d 1H/13C-NMR 
spectroscopy and determined as N-sitosterol-3-O-N-D-glucoside, a triterpene 
compound widely occurring in plants. For this structure dietary effects are known, 
N-sitosterol and its corresponding glucoside participate in cholesterol-lowering 
activities of certain plant preparations. The compound acts as a competitive 
inhibitor in cholesterol resorption from nutrition as well as cholesterol reabsorption 
from enterohepatic circulation. Furthermore, N-sitosterol is used in prostata 
therapy (prostate hyperplasia, BHP), but the mechanism of this effect is not known 
yet. Platelet anti-aggregatory effects of N-sitosterol have been described in 
literature (Awad et al. 2001[98], Jourdain et al. 2006 [99], Wilt TJ et al. 1999 [100]). 
With regard to the literature, it can be said, that N-sitosterol and its corresponding 
glucoside probably play an important role in the platelet anti-aggregatory effect of 
wild garlic fractions as we observed. The second compound found was fraction 11-
17/4-6. Measurement by ESI mass spectrometry and structure elucidation using 
the NMR methods mentioned above revealed that this compound is the 
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cerebroside-like monogalactosyl-dilinolenoylglyceride. In our experiment, this 
compound displayed high platelet antiaggregation activity. This compound was 
described as a constituent of the chloroplast membrane (Poincelot RP 1976 [92], 
Webster and Chang 1969 [101]). 
Amazingly, this compound mainly is a topic of plant physiological investigations; to 
our knowledge biological activities of medicinal or pharmaceutical interest are not 
described or published till now. This could imply, that in this work the cerebroside-
like component is described as a bioactive compound in a human test model for 
the first time. Maybe this compound or an Allium ursinum lipophilic extract can be 
used as a potent platelet aggregation inhibitor. 
Regarding the high yield achieved of the cerebroside-like substance in our 
experiment, together with the high content of N-sitosterol, of sulfide compounds 
like diallyl sulfides and viyldithiins and of the saponosides also described as 
platelet aggregation inhibitors; wild garlic is shown as a potent medicinal plant to 
treat thrombotic disorders. 
It was clear during the project that both Allium ursinum and Allium sativum exhibit 
their antiaggregatory effect through the ADP mechanism, and to a lower extent 
aggregation induced by epinephrine. It became clear that the alcoholic extract of 
the Allium ursinum is the potent form while the aqueous had an unspecific activity. 
Effects were strictly dose related. 
The chemical structures for the active compounds in fraction 11-17/1 and 11-
17/15-20 could not be characterized because of the small amount of the material 
and the high content of chlorophyll in these fractions. For fraction 11-17/1 a very 
lipophilic compound could be assumed, shown as an intense violet spot after 
4 Discussion   
110
detection by TLC analysis, and there is a high possibility for the presence of N-
sitosterol (not N-sitosterol glucoside!). The active principle could be also in context 
with a single fatty acid; the biological activities of fatty acids are subject of recent 
investigations, in nutrition investigations as well as in pharmaceutical science. 
Fraction 11-17/15-20 also showed high inhibitory activity. Regarding TLC, the 
trace of 15-20 shows a high amount of chlorophylls and a violet spot with the same 
Rf value like N-sitosterol glucoside. Maybe this compound is also constituent of 
this fraction together with further unknown compounds with synergistic or 
supporting effects. The active component of this fraction could not be isolated. 
Maybe the active components are the aglycones of the garlic saponosides like 
eruboside B, sativoside and tigonine, but this cannot be proven within the present 
study. The other active compounds of the chloroform extract (or other comparable 
lipophilic extracts) of wild garlic can be subjects for further investigations. 
Bioassay-guided isolation and structure elucidation of the other active components 
could explain the mechanisms of platelet antiaggregatory effects of wild garlic and 
common garlic. 
Based on the results of this work, a wild garlic refined extract could be developed 
for usage in prevention and therapy of disorders induced by increased platelet 
aggregation which needs to be tested in vivo animal models of thrombosis. 
The investigation presented here shows clear antiaggregatory effects in particular 
against ADP-stimulated platelet aggregation. These fractions of the chloroform 
extract all are unpolar compounds.  
The interaction between the ADP receptor and these compounds considered 
above is not directly explainable; the molecule shows not much similarity to the 
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ADP molecule; a direct substrate inhibition cannot be considered. Since in our test 
model the arachidonic acid-induced platelet aggregation seems also to be 
affected, although to a lesser extent, a COX-inhibiting antiaggregatory action may 
also contribute to the overall antiaggregatory effect. Similarly, Weil et al. 2005 [93] 
have described compounds chemically similar to those of the present work 
presented here acting as COX inhibitors. It is to say, that there are several test 
systems for COX inhibition. Maybe our results could be confirmed by another 
study using the COX-1- and COX-2 system directly. 
 
Finally, this work affirms similar activity in platelet aggregation inhibition of Allium 
ursinum comparable to that of Allium sativum. It could be shown, that the inhibition 
is dose-dependent. The results of this work describe that the activity is found in 
extracts of different polarities, whereas considering the test models used the most 
lipophilic extracts exhibited highest antiaggregation inhibition. For the chloroform 
extract the ADP-antagonistic way of inhibition could be detected for the lipophilic 
extract. Two compounds could be isolated from the chloroform extract by repeated 
normal phase column chromatography. Structure elucidation by ESI-MS and 1d/2d 
1H/13C-NMR spectroscopy revealed Nsitosterol-3-O-N-D-galactoside and 1-N-D-
galactosyl-2,3-dilinolenoyl glycerate, two compounds of a large lipophilic moiety 
and a small polar part. For these components aggregation inhibition was 
evidenced in ADP-stimulated platelet test model. 
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